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(This Chapter contains previously published material. See Appendix B.)	
INTRODUCTION	
Hypertension is a multifactorial condition rather than a single disease entity whose 
onset can be brought about through a variety of factors originating from environmental, 
dietary, or hereditary factors. The complex interplay of these components has frustrated our 
understanding of hypertension, despite decades of research spent attempting to identify its 
causes and develop viable treatments. Even today, less than 20% of all hypertensive cases 
have a known etiology (referred to as secondary hypertension) with the basis for the 
remaining majority of cases being unknown (referred to as primary or essential 
hypertension) [1, 2]. Studies of the U.S. population have found that 29% of adults are 
hypertensive, and this number is only expected to increase dramatically in the near future 
[3]. Unfortunately, elevated blood pressure is becoming increasingly prevalent in people 
under the age of 40 years [4]. Despite the fact the proportion of individuals with controlled 
blood pressure (systolic < 140 mmHg; diastolic < 90 mmHg) in the U.S. has increased from 
28.4% to 43.5%, in low and middle-income countries control of blood pressure has actually 
decreased to 7.7% [5, 6]. Indeed, even mild increases in either systolic or diastolic pressure 
(< 10 mmHg) are accompanied by increases in mortality rates [7]. The increased prevalence 
of hypertension has coincided with an equally sharp increase in the incidence of chronic 
kidney disease that has been attributed, at least in part, to substantial changes in dietary 
intake and sedentary lifestyle [4, 8]. Hence, there has been an increased effort to develop 
new models of hypertension that better reflect the environmental and dietary behaviors of 
modern society. Several models of diet-induced hypertension exist that are well established, 
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namely those high in fat or sodium [9, 10]. Models of metabolic syndrome induce a 
constellation of medical conditions accompanying insulin resistance such as obesity, 
hyperglycemia, hypertension, and dyslipidemia [11]. Given the widespread use of fructose 
as a sweetener in food products, several recent reviews have discussed the impact of fructose 
ingestion on obesity and hypertension within the metabolic syndrome [12, 13] and the 
hormones involved [14]. The present review focuses on recent interest on the consequences 
of even mild fructose consumption independent of full-blown metabolic syndrome with 
particular attention to the role of the kidney and the sympathetic nervous system on blood 
pressure. 
FRUCTOSE	CONSUMPTION,	HYPERTENSION,	AND	MORTALITY			
Total fructose consumption includes that which is found in high fructose corn syrup 
(HFCS) and sucrose. Generation of HFCS began in the late 1950s when it was discovered that 
glucose, hydrolyzed from corn starch extracts, could be partially converted to fructose 
through enzymatic isomerization [15]. Over time, this process was industrialized and led to 
the development of the corn-derived sweetener, HFCS, which can be synthesized with 
varying ratios of fructose to glucose content. Ease of synthesis, comparable flavor, and low 
cost of this ingredient have contributed to its widespread use as a sweetener [16]. Between 
1970 and 2006, fructose consumption drastically increased, amounting to approximately 
50% of all per capita added sugar consumption. This increase is accounted for solely by an 
exponential increase in free fructose consumption in the form of HFCS. During this time, 
caloric intake from total sugar (HFCS, sucrose, and other natural sugars) and fats increased 
significantly contributing to a 41% increase in total carbohydrate intake, of which fructose 
consumption provided a primary source [17]. 
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HFCS appeals to nearly every demographic leading to its widespread use in food 
products. Statistical analysis of data collected in the National Health and Nutrition 
Examination Survey (NHANES I-III) determined that HFCS is most heavily consumed in the 
form sugar-sweetened beverages, and this trend is consistent throughout all age groups and 
sexes. Although a recent meta-analysis of three prospective studies fails to show incident 
hypertension associated with fructose, these studies relied on self-reports of dietary intake 
and physician-diagnosed hypertension and did not include concurrent sodium intake [18]. 
In contrast, another meta-analysis (n = 240,508) that includes data from the Coronary Artery 
Risk Development in Young Adults (CARDIA) cohort (n = 240,508) [19] and quoted by the 
recent American Heart Association update on stroke reports a 12% greater risk of 
hypertension with consumption of sugar sweetened beverages when controlled for sex, age, 
race, BMI and smoking behaviors [20]. Compared with the increased risk associated with 
more traditional factors such as alcohol consumption (61%), smoking (21%), and red meat 
intake (35%) and sedentary life style (48%) [21-24]	or the non-traditional risk of stress (5-
12%) [25], the risk associated with fructose intake may appear small but is nonetheless real. 
Whether the risk of hypertension associated with fructose is modified by combination with 
higher sodium intake has not yet been rigorously evaluated in humans, but the role of 
combined intake in preclinical studies is discussed below. 
Adolescents and young adults are the highest consumers overall, and people in lower 
income population sectors are more likely to consume HFCS than those in more affluent 
demographic groups [13]. The rise in fructose consumption over the past several decades 
has been accompanied by an increase in obesity in the United States, and these rates parallel 
those of hypertension in a nearly linear relationship between body mass index and blood 
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pressure [26, 27]. Although several human studies have shown that high fructose 
consumption contributes to weight gain and blood pressure elevation, there is still 
controversy over the extent to which HFCS consumption is correlated with the historical 
obesity and hypertension trends [28]. Factors such as overall increase in national 
carbohydrate consumption make it challenging to discern increased fructose intake as a 
primary etiologic source for these disease states [17]. Nevertheless, the ingestion of fructose 
induces several physiologic responses that favor weight gain and increased blood pressure.  
The most recent NHANES III survey found that as of 2004, the average daily intake of 
fructose (49 grams) in the U.S. equated to 9.1% of total energy intake [17]. Interestingly, 
commercially available drinks using HFCS have up to 140 calories from added sugars per 12 
fluid ounce container. Given the most commonly used HFCS composition of 55% fructose 
and 45% glucose, this amounts to approximately 25 grams or 100 calories from fructose 
alone. This quantity from one drink alone nearly surpasses the American Heart Association 
recommendation of only 150 and 100 calories from added sugars per day for men and 
women, respectively [29]. Animal studies designed to model this trend in human dietary 
intake have used various dietary fructose compositions - many of which exceed 60% of total 
daily caloric intake [30-32]. Increased fructose ingestion in either humans or animal studies 
have demonstrated significant hemodynamic changes even after limited periods of time [28, 
33, 34]. Interestingly, most animal studies were not accompanied by significant increases in 
body weight, suggesting that factors apart from obesity may contribute to the hypertensive 
phenotype [30, 31]. Chronic animal models using more moderate fructose intake that is 
consistent with heavy human consumption (15-20% of daily caloric intake) demonstrate 
cardiovascular and metabolic changes similar to human subjects, although the timeline by 
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which these occur may be skewed [35, 36]. The role of endothelial dysfunction has been 
reviewed in detail [37, 38]. Mechanisms involved in the early phases of sodium absorption 
by the intestine have been studied to a greater extent [39]; however, renal sodium 
reabsorption [40], the renal renin-angiotensin-aldosterone (RAS) system [41], and 
sympathetic nervous system [32, 42] have received more limited attention.  
FRUCTOSE	INFLUENCE	ON	SODIUM	HANDLING	AND	BLOOD	PRESSURE	
Fructose	influences	on	gastrointestinal	sodium	absorption	
Sodium homeostasis is a critical component of blood pressure regulation and has 
been linked to various cardiovascular and renal complications, including hypertension [43-
46]. Glucose intake is coupled to Na+ transport via the luminal sodium-glucose-linked 
transporters 1 and 2 (SGLT1 and SGLT2). Intracellular glucose concentration is largely 
maintained through the glucose transporter 2 (GLUT2) isoform along the basolateral 
membrane. Chronically, fructose and glucose (but not other sugars) lead to an increase in 
GLUT2 protein expression along the basolateral membrane [47]. Similar to GLUT5, GLUT2 
has a much lower affinity for glucose than other isoforms and therefore functions primarily 
as a fructose transporter [48]. Fructose transport is facilitated by a downhill concentration 
gradient between the intestinal lumen and intracellular space [39, 49, 50].  
On the other hand, sodium absorption occurs throughout the small intestine via a 
variety of transport systems. SLC26A6 (human), also known as the putative ion transporter 
1 (PAT1), is a multifunctional apical chloride/base exchanger that increases with fructose 
feeding in both the jejunum [39, 51] and kidney [52]. The function of PAT1 is coupled with 
that of the intestinal Na/H exchanger 3 (NHE3) so that Na+ is reabsorbed with Cl- in an 
electroneutral manner [53, 54]. The presence of fructose amplifies NHE3 function, thereby 
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enhancing absorption of Na+ and secretion of H+ [39, 40, 42]. PAT1 also co-localizes with 
GLUT5 (Slca5), a member of the glucose transporter family, with low affinity for glucose and 
high affinity for fructose. GLUT5 is the dominant fructose transporter in the jejunum.  
Despite the changes in both sodium and sugar transporters, the impact of fructose on 
overall gastrointestinal absorption and ultimate fecal excretion of sodium has been given 
scant investigative attention. An increase in dietary sodium does not increase absolute fecal 
sodium excretion in Sprague Dawley rats independent of whether the high sodium chow is 
delivered with glucose or fructose in the drinking water or with water alone. Gastrointestinal 
sodium absorption increases as dietary intake of sodium increases regardless of the 
presence or type of sugars in the diet. Thus, the task for excretion of the greater total body 
sodium content relies on the kidney. Notably, urinary sodium excretion is significantly 
diminished in fructose-fed rats resulting in a positive sodium balance [41]. The renal 
mechanisms that are understood to date are detailed below. 
Fructose	influences	renal	sodium	reabsorption	and	RAS		
The bulk of Na+ reabsorption in the mammalian kidney occurs in the proximal tubule, 
which is responsible for reabsorption of 60-70% of all Na+ and fluid filtered by the 
glomerulus [55]. Similar to the intestine, GLUT2, GLUT5, NHE3, and several isoforms from 
the SGLT family facilitate the reabsorption of Na+. Proximal tubule Na+ reabsorption is reliant 
on secondary active transport by co-transporters such as NHE3 and SGLT isoforms, 
particularly SGLT2 [56]. Fine tuning of ionic concentrations and gradients is critical to blood 
pressure homeostasis. Perturbation such as augmented proximal tubule Na+ reabsorption 
results in increased fluid reabsorption, leading to a net positive sodium balance predisposing 
to hypertension. This mechanism has been linked to hypertension in spontaneously 
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hypertensive rats [57] and Dahl salt-sensitive rats [58]. In carefully executed balance studies, 
Gordish et al. [41] showed that rats given 20% fructose in their drinking water and placed 
on high salt diet displayed significantly greater cumulative Na+ balance compared with rats 
given only water or 20% glucose in their drinking water. These findings strongly supported 
a role for fructose-feeding on renal Na+ balance. Notably, except for elevated triglyceride 
levels in the fructose-fed high salt group, there were no differences in fasting plasma glucose 
and body weights between fructose-high salt-fed rats and glucose or water controls either 
with standard or high salt intake [41]. 
In the proximal tubule, the large proportion of filtered Na+ and bicarbonate (HCO3-) 
reabsorption is linked to Na+/H+ exchange, via NHE3 [59]. Acute in	 vivo microperfusion 
studies of proximal tubules from Wistar rats exposed to fructose revealed enhanced NHE3 
activity. The increase in NHE3 activity was corroborated by in	vitro studies showing greater 
Na+ dependent H+ flux in the presence of fructose associated with diminished PKA activity in 
cultured LLC-PK1 cells, a porcine cell line [60]. Fructose, but not glucose, increased NHE3 
activity by isolated rat proximal tubules via a PKC-dependent pathway and further 
potentiated the effects of picomolar concentrations of angiotensin II (Ang II) to increase 
Na+/H+ exchange. Na/K-ATPase activity did not change [40]. Moderate amounts of fructose 
consumption (approximately 40% of daily caloric intake provided as a 20% fructose solution 
in drinking water) increased tail cuff blood pressure in rats. Proximal tubule expression 
levels of NHE3 increased significantly in the fructose-fed compared to that of control rats, 
whereas α1 subunit of the basolateral Na/K-ATPase did not. Moreover, proximal tubules 
isolated from these rats also showed enhanced Na+ reabsorption that was potentiated by Ang 
II [61, 62].   
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The proximal tubule thus appears to become sensitized to Ang II via a PKC 
mechanism, to which the addition of high Na+ intake leads to substantial reabsorption rates. 
Further, this sensitization extends beyond the proximal tubule into the thick ascending limb 
and other Na+ transport mechanisms in the distal nephron, although studies have reported 
some conflicting results. An early study with 65% dietary fructose failed to observe a change 
in overall NKCC2 abundance in the kidney [63]. In	 vitro and in	 vivo studies have shown 
similar effects on Na+/K+/2Cl- co-transporter 2 (NKCC2) expression and activity. Acute in	
vitro administration of fructose to the thick ascending limb increases NKCC2 activity by 
increasing protein expression and not phosphorylation along the apical membrane [64]. 
Chronic in	vivo studies using furosemide, an NKCC2 antagonist, to measure acute diuretic 
and natriuretic responses following NKCC2 blockade found that high fructose-induced 
hypertension led to significant increases in urine output as well as in urinary potassium, 
chloride, and sodium concentration. This was reflected by significant increases in NKCC2 
mRNA and protein expression [65]. Together, these alterations in transporter expression 
and activity throughout the nephron facilitate plasma volume expansion which is 
responsible, at least in part, for the observed hypertension. 
The importance of sensitization to Ang II also cannot be understated. Several 
preclinical studies have shown that even moderate consumption of fructose and Na+ can 
have considerable adverse effects on blood pressure [41, 42, 61, 66]. With the profound 
increases in Na+ retention observed in the various models of fructose-induced hypertension 
with expected extracellular volume expansion, it would be anticipated that plasma renin 
activity (PRA) would be suppressed. Further investigation by others reported blunted 
suppression of PRA in Sprague Dawley rats given 20% fructose for one week,  followed by 
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one week of fructose plus 4% NaCl diet [41, 66]. In contrast, extending the high salt intake 
period to 3 weeks, Soncrant et al. confirmed the elevation in blood pressure using telemetric 
monitoring and were able to demonstrate inhibition of PRA and plasma Ang II in fructose-
fed rats [42]. Thus, it appears that PRA which is typically inhibited by either high blood 
pressure or expanded extracellular volume requires a longer period of exposure to either of 
these inhibitory influences in the context of high fructose intake. In other words, a much 
greater expansion of extracellular volume and, therefore a longer period of positive 
cumulative Na+ balance, may be required to inhibit renin secretion with concomitant 
fructose-feeding.  
It is also possible that intrarenal RAS contributes to hypertension and increased Na+ 
reabsorption with fructose feeding. Early studies indicated that renal tissue renin expression 
was suppressed in fructose-fed mice [39] yet increased in rats fed 20% fructose for 12 weeks 
[65]. Renal tissue Ang II levels were not statistically different from control glucose-fed rats 
on high salt diet for 3 weeks despite higher blood pressure [42]. Notably, renal angiotensin 
AT1 receptor mRNA was increased in adipose tissue but not kidney after three weeks of high 
fructose ingestion [67]. When fructose was given in greater amounts (60 to 66% in the 
drinking water) and for longer periods of time (8 to 16 weeks), both Ang I and Ang II as well 
as AT1 receptor protein expression was increased in kidney tissue [68, 69]. Alternatively, 
the third influence on renin secretion involves sympathetic inputs to the macula densa. 
Indeed, switching from standard diet (0.4% NaCl) to high salt (4% NaCl) diet in fructose-fed 
rats increases renal sympathetic nerve activity by ~ 50% [42]. Denervation of the kidneys 
bilaterally using cryo-techniques further decreased the already suppressed PRA suggesting 
sympathetic inputs to the kidney were responsible for the enhanced renin secretion. 
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Notably, neither the diets nor denervation altered tissue Ang II content compared with 
controls [42]. 
In addition to the experimental dietary manipulations, some of the variability in these 
studies likely stems from methodology used such as the technique for blood pressure 
assessment (tail cuff vs telemetry), the time when fructose is initiated relative to the high 
salt diet, the length of exposure to each component of the diet, and the methodology for 
collection of blood or tissue for measurements of renin, plasma Ang II or their tissue levels. 
Regardless of the impact of these factors, the findings that a diet enriched for fructose 
sensitizes the nephron to Ang II such that even minimal activation of the RAS can have 
profound sodium reabsorption effects. 
Fructose	influences	on	the	renal	sympathetic	nervous	system	
The scientific interest in sympathetic innervation of the kidney has increased recently 
after the demonstration of marked reductions in blood pressure in individuals with resistant 
hypertension after denervation using the catheter-based approach [70, 71]. Renal 
sympathetic nerve activity (RSNA) is significantly increased in many forms of experimental 
hypertension (reviewed by Osborn and Foss [72]), reinforcing the vital role of RSNA in blood 
pressure regulation. The mechanisms of increased RSNA in the pathogenesis of hypertension 
include increased tubular sodium reabsorption and water retention, decreased renal blood 
flow and glomerular filtration rate, and increased renin secretion from the juxtaglomerular 
cells which activates the renin-angiotensin system [73]. Since moderately high dietary 
fructose and salt cause hypertension via similar mechanisms, it has been hypothesized that 
sympathetic activity increases in this dietary milieu. In fact, ingestion of fructose has been 
shown to result in changes in secretion of hormones that regulate energy balance [74], a shift 
11 
 
associated with increased sympathetic nervous system activity [75]. The hormone leptin 
which promotes satiety is released from adipose tissue cells to maintain energy balance by 
promoting satiety. In contrast, ghrelin opposes this action and promotes hunger. Ingestion 
of fructose leads to simultaneously increased secretion of ghrelin and decreased secretion of 
leptin. After chronic ingestion of excess dietary fructose (over 1 to 4 weeks), fasting plasma 
concentrations of leptin are significantly higher [76]. The mechanistic basis for elevated 
leptin levels likely stems from fructose-induced fatty acid re-esterification and synthesis of 
VLDL-triglycerides. This pathway causes a shift towards the fat-storing mode, prompting the 
adipose cells to respond by elevating leptin production. Simultaneously, augmentation of 
RSNA occurs initiating the onslaught of hypertension-promoting effects.  
Fuctose‐induced	endothelial	dysfunction		
The general mechanisms by which the fructose induces increased sodium absorption 
and retention and how this ultimately leads to increased extracellular volume and 
hypertension are well defined. The hypertensive states are maintained by two additional 
overarching pathologies: increased sympathetic activity (regional and systemic) and 
endothelial dysfunction [77].  As noted, increased sympathetic activity to the kidney causes 
increased sodium reabsorption as well as blunts inhibition of renin secretion, despite 
increased plasma sodium levels. Sympathetic activity to the vasculature produces 
vasoconstriction which, in turn, increases arterial pressure. Chronic fructose feeding has 
been shown to induce over-activation of the sympathetic nervous system that leads to 
increased systemic resistance, accompanied by an increase in plasma norepinephrine. 
Increases in arterial pressure in this study were ameliorated by alpha1-adrenoreceptor 
blockade [78]. Much of this sympathetic drive is postulated to originate from increased 
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plasma insulin levels, which in turn exacerbate insulin resistance and a positive feed-back 
loop that promotes further sympathetic drive [32].  
While increases in arterial pressure are occurring via sympathetic, humoral, and 
volume-dependent mechanisms, additional factors are simultaneously inducing further 
endothelial dysfunction that may lead to permanent vascular remodeling. Fructose-induced 
hyperinsulinemia leads to disruptions of endothelial systems such as lowered activity and 
expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1); both of 
which alter vascular tone and increase vasoconstriction [36, 79, 80]. Thromboxane A2 and 
angiotensin II (Ang. II) are also potent vasoconstrictors whose upregulation have been 
observed in fructose studies and have been linked, at least in part, to increased ET-1 
expression [81-83]. Each of these vasoactive proteins - ET-1, Ang. II, and thromboxane A2 – 
can act independently or in concert to degrade endothelial membrane proteins by way of 
matrix metalloproteinase up-regulation. It has been proposed that this pathway of 
endothelial dysfunction ultimately leads to further degradation of eNOS and therefore 
increased arterial pressure. This situation is true in the context of hyperinsulinemia and has 
also been shown in instances of high dietary fructose consumption, where matrix 
metalloproteinases isoform 2 upregulation reduces nitric oxide (NO) levels. [84].  
EXPERIMENTAL	PURPOSE	AND	DESIGN	
	 In	vitro	and in	vivo	research has provided us with extensive knowledge regarding the 
pathologies of fructose-induced hypertension. However, much of this research has been 
conducted using irrelevantly high quantities of fructose that without question implicate 
influential pathologic mechanisms such as hyperinsulinemia and hyperglycemia. The 
benefits of using a model with lower levels of fructose to induce states of salt-sensitivity are 
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not only particularly relevant to modern consumption trends, but also promote an avenue of 
study in which the multifactorial nature of hypertension can be further elucidated without 
confounding factors such as insulin resistance. The purpose of this research was to utilize a 
model of hypertension such as this to elucidate not only the mechanisms by which it occurs, 
but also to determine the extent by which such mechanisms induce end-organ damage. The 
studies detailed in the following chapters were designed to investigate the end-organ 







(This Chapter contains previously published material. See Appendix C.) 
INTRODUCTION	
Hypertension prevalence is currently estimated at 46% among adults in the United 
States and remains one of the top healthcare and societal burdens [85]. Chronic increases in 
arterial pressure contribute to the development of comorbidities and major adverse cardiac 
events (MACE) such as stroke, myocardial infarction, heart failure, and renal disease [86]. 
Despite the urgent need to implement strategies for incidence reduction, the etiologies 
underlying the majority of hypertensive states still remain unknown. In addition to genomic 
factors, environmental factors including suboptimal dietary habits also contribute to the 
development of hypertension. Consumption of fructose has been on the rise due to 
increasing use of high fructose corn syrup since the 1970’s for sweetening beverages and 
pre-packaged foods [13]. A recent meta-analysis found that individuals consuming sugar-
sweetened beverages in the highest versus lowest quantile displayed a greater risk for 
hypertension [19]. The association between fructose ingestion and hypertension is 
potentiated by increased salt intake [87]. Indeed, a typical Western diet is enriched in both 
fructose and salt.  
Previous work in the fructose-induced salt sensitive hypertension rat model showed 
increased reactive oxygen species (ROS) production, diminished nitric oxide bioavailability 
and cumulative positive sodium balance [41, 88]. Activation of the renin-angiotensin-
aldosterone system (RAS) and increased renal sympathetic nerve activity, both of which 
promote increased renal tubular sodium reabsorption, have also been implicated as 
mechanisms resulting in elevated arterial pressure [41, 42, 62, 66, 89]. Notably, bilateral 
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renal cryo-denervation [42] or daily treatment with the superoxide dismutase mimetic, 4-
hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (+T; Tempol), reduces 8-isoprostane 
excretion and ameliorates the hypertension.[66] In light of these findings, it is possible that 
combined fructose and high salt diet may exert a deleterious impact cardiac and vascular 
function either directly or indirectly via the elevated arterial pressure. If so, then it would be 
important to evaluate whether 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl also 
ameliorates cardiovascular function in this model.  
Data from the Framingham population highlight that aortic stiffening precedes 
hypertension.[90, 91] The force of ejected blood during cardiac systole exerts pressure on 
the aortic wall that makes the normal aorta expand and then recoil back during cardiac 
diastole. This property of healthy aorta is known as the Windkessel function, or capacitance, 
and functionally is responsible for reduction of systolic blood pressure and maintenance of 
peripheral perfusion during diastole.  As the aorta stiffens such as occurs physiologically in 
aging and pathophysiologically in diabetes, obesity and hypertension, it loses the Windkessel 
function which is reflected in increases in pulse wave velocity (PWV) [92, 93].  Accordingly, 
aortic PWV is one of the most reliable predictors of cardiovascular mortality as 
demonstrated by two major meta-analyses [94, 95]. Elastic properties of major vessels can 
also be assessed with strain imaging as demonstrated by a recent study describing 
reductions in common carotid artery strain as a valuable tool for detection of atherosclerotic 
disease.[96] Likewise, a decrease in ascending aortic strain is an independent predictor of 
significant coronary artery disease in patients with coronary artery stenosis ≥70% [97]. 
Given the interdependence of systemic and renal hemodynamics, it is tempting to 
speculate that aortic stiffening is expected to have deleterious consequences on the renal 
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vasculature. Renal resistive index (RRI) measured with intrarenal Doppler ultrasound is 
influenced by complex interactions between vascular wall properties and systemic factors 
and can be used to identify vascular dysfunction [98]. Higher RRI is associated with 
increased PWV [99] and leads to microvascular damage over time [100]. The effects of 
fructose-induced salt-sensitive hypertension on the elastic properties of conduit and 
resistance vessels are presently undefined. Even in the absence of hypertension, salt-
sensitivity in humans constitutes a cardiovascular risk factor [101, 102]. It is unknown 
whether fructose predisposes to salt-sensitive hypertension by reduced aortic compliance, 
increased PWV and consequential perturbations in renal hemodynamics via the ROS system. 
However, such a process could link fructose and high salt ingestion with hypertension and 
may explain how fructose induced salt sensitive hypertension leads to systemic and renal 
hemodynamic derangements. 
In the present investigation, we employed the fructose-induced salt sensitive 
hypertension rat model by feeding rats 20% (w/v) fructose for one week, followed by the 
addition of 4% NaCl for three more weeks, which results in increases in mean arterial 
pressure[42]. We hypothesized that dietary fructose, rather than glucose, in combination 
with high salt will lead to aortic stiffening, evidenced by increased aortic PWV, decreased 
strain, and decreased distensibility coefficient. This will, in turn, result in an increase in RRI. 
We hypothesize that daily supplementation with the antioxidant, 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl, will ameliorate the increase in mean arterial pressure, and 
thereby mitigate vascular stiffening. These studies are aimed at identifying the diverse 
mechanisms that diminish aortic compliance, impair renal vascular function, and contribute 





Male Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN) were housed 
under controlled conditions (21–23°C; 12 hr light and 12 hr dark cycles, light on at 7 am) 
and were permitted ad libitum access to water and standard rat chow containing 0.4% NaCl 
until they were enrolled into experimental protocols described below. Complete care 
provided to rats was in accordance with the principles of the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals. All procedures and protocols were 
approved by the Wayne State University Institutional Animal Care and Use Committee 
(Protocol #19-01-1001).  
Dietary	regimen	
Upon arrival of animals to the DLAR facilities, all rats were provided ad libitum access 
to 0.4% NaCl standard chow (Envigo Teklad, Madison, WI) and normal water. Three to five 
days later, hemodynamic telemetry devices were implanted, and rats allowed to recover for 
three-four days in single housing. Following previously established protocols, 6,9,10 the rats 
were randomized to either 20% (w/v) glucose (Sigma-Aldrich, St. Louis, MO) or 20% (w/v) 
fructose (Sigma-Aldrich, St. Louis, MO) and maintained 0.4% NaCl chow. The age of rats at 
enrollment was 10-12 weeks and the average weight was 228.6 ± 5.9 g in the control group 
and 225 ± 2.5g in the Tempol group. Glucose was provided in the control groups to match 
both caloric and fluid intake. The consumption of glucose and fructose was similar 
throughout the protocol (~65 kcal per day as carbohydrate). After one week, the rats were 
randomly assigned to one of eight groups: 1) glucose and normal (0.4%) salt (Glu+NS), 2), 
glucose and high (4.0%) salt (Glu+HS), 3) fructose and normal salt (Fru+NS), 4) fructose and 
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high salt (Fru+HS), 5) Glu+NS with the addition of 4-hydroxy-2,2,6,6-tetramethyl-
piperidine-1-oxyl (+T) (Glu+NS+T), 6) Glu+HS+T, 7) Fru-NS+T or 8) Fru+HS+T).  
To assure that each rat in the groups receiving +T (Santa Cruz, Santa Cruz, CA) 
received the full dose, 35 ml of the respective drinking mixture was supplemented with +T, 
15 mg/400 g body weight. After the rat completed drinking the allotted antioxidant solution, 
a fresh water bottle with the respective glucose or fructose supplement alone was provided. 
This approach allowed verification that each rat received its full dose of anti-oxidant and that 
fructose or glucose ingestion across all groups was similar. The respective dietary regimens 
were continued for three weeks with monitoring of hemodynamic parameters via telemetry.  
Surgical	procedures	
Hemodynamic telemetry transmitter placement. All rats were instrumented with 
hemodynamic telemeters at ten weeks of age (~225 g body weight) under ketamine (80 
mg/kg) and xylazine (10 mg/ml) anesthesia. An incision was made in the groin and a 
hemodynamic telemetry transmitter (TA11PA-C40, Data Sciences International) implanted 
by exposing the right femoral artery, temporarily occluding the proximal end, and inserting 
the gel-filled catheter attached to the transmitter device into the artery with a 21-gauge 
needle. The catheter was advanced into the abdominal aorta and the transmitter tunneled 
subcutaneously. The incision was closed using surgical staples. Post-operative analgesia was 
provided with buprenorphine SR (0.3 mg/kg subcutaneously).   
Vascular catheter placement. At the end of the fourth week (1 week glucose/fructose 
+ 3 weeks ± Tempol®), the rats were instrumented with carotid arterial catheters for 
hemodynamic monitoring during ultrasonography and for collection of aortic blood at the 




Data acquisition of hemodynamic parameters was performed using Dataquest ART 
software (Data Sciences International, Saint Paul, MN). Measurements of heart rate, systolic 
(SBP), diastolic (DBP), and mean arterial pressures (MAP) as well as the derived pulse 
pressure (PP) were sampled for 10 sec at a sampling rate of 500 samples/sec every 1 hr for 
the remainder of the 3-week protocol. The average of hemodynamic recordings initiated 
during the last three days of the week during which the rats were on glucose or fructose and 
0.4% NaCl were taken as baseline. Once assigned to one of the eight groups (see above), 
hemodynamic measurements over the next three weeks were taken for 24 hr beginning at 7 
am (lights on) during Mondays and Thursdays in order to avoid cage cleaning days and 
disruptions (e.g., weekend changes in veterinary staff) that could impact the parameters as 
well as conserve transmitter battery time.  Values are the 24-hr average for a given day.   
Two days after placement of vascular catheters, echocardiography and renal Doppler 
scans were completed by an investigator blinded to the group assignments. Blood pressure 
and heart rate were monitored continuously with PowerLab (ADInstruments, Colorado 
Springs, CO) connected to the LabChart 8.0 software.   
Rats were anesthetized with 3% isoflurane in an induction chamber, and 
maintenance of anesthesia was achieved with 1.5% isoflurane delivered via a nose cone. 
Scans were performed on the heated platform (Fujifilm Visualsonics, Inc., Toronto, Canada) 
in a supine position with all four limbs secured to ECG electrodes with tape. Fur was removed 
from the chest and abdominal areas first by shaving the area followed by a cream depilatory 
(Pharmaceutical Innovations, Newark, NJ), before applying contact gel preheated to 37°C. 
Body temperature was monitored using a rectal probe. Echocardiographic recordings were 
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made according to standard methods[103, 104] at the conclusion of the three-week dietary 
intervention. Images were acquired using a Vevo3100 with an MX-250S transducer (Fujifilm 
Visualsonics Inc.). A parasternal short axis view was used to obtain images in M-mode at the 
level of papillary muscles to assess systolic function and left ventricular dimensions. Left 
ventricular diastolic function was ascertained using pulse wave Doppler recordings of 
transmitral flow velocities aligned in the apical four chamber view. Aortic PWV was 
determined using B-mode and pulse wave Doppler of aortic flow velocities at two positions 
along the aortic arch [105]. Briefly, the time to initiation of flow was determined relative to 
the ECG and the difference calculated. The distance between the two flow positions, 
determined along the B-mode image, was then divided by the time to calculate the PWV.   
The renal resistive index (RRI) was ascertained using pulse wave Doppler imaging of 
flow through the left main renal artery. The RRI was calculated as the difference between the 
peak systolic and minimum diastolic velocity, divided by the peak systolic velocity [98].  
Aortic distensibility and strain were derived from the B-mode images. Some measurements 
were not able to be technically ascertained in each animal due to anatomical constraints. 
Data analysis was completed offline in blinded fashion using VevoLab and VevoVasc 
software (Fujifilm Visualsonics, Inc.).     
After all scans were completed, the rats were permitted to recover from isoflurane 
anesthesia and allowed to regain normal activities for ~4-6 hr. Arterial blood was then 
collected in the conscious animals using the carotid catheter for hormone analyses. Blood (1 
ml) was taken over 90-sec period into pre-chilled tubes containing 50 µl sodium 
ethylenediaminetetraacetic acid (EDTA) for PRA.  Another 1.5 ml of blood was taken into a 
separate pre-chilled tube with 120 µl of 500 mM sodium EDTA, 125 mM phenanthroline, 1 
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mM phenylmethanesulfonyl fluoride, 20 mM pepstatin, 1 mM enalapril and 10X phosphatase 
inhibitor cocktail for Ang II.  The blood was immediately centrifuged at 3000 rpm at 4°C, and 
the plasma stored at -70°C until assay.   
The rats were then euthanized with pentobarbital (100mg/kg) and hearts and 
kidneys harvested and weighed while keeping them cold in saline. The renal cortex was then 
rapidly and sharply dissected, and the tissue frozen at -70°C until analyzed for tissue Ang II. 
Hormone	assays	
All tests were performed on blood samples obtained simultaneously between 1 pm 
and 4 pm. Non-fasting blood glucose concentrations were measured with One Touch Ultra 2 
(Lifescan, Switzerland). Plasma renin activity (PRA) (IBL International, Hamburg, Germany) 
and insulin (Cayman, Ann Arbor, MI) were measured by enzyme-linked immunosorbant 
assays according to the product directions. Plasma and tissue angiotensin II (Ang II) 
concentrations were assessed by radioimmunoassay as previously described by our 
laboratory [106].  
Analyses	and	statistics	
Heart rate and arterial pressures were collected using Dataquest ART software (Data 
Sciences Intl, St. Paul, MN) and averaged over a 24 hr period. All analyses were performed 
by a researcher blinded to the group assignments.  Results are presented as mean ± SE. 
Comparisons among groups were completed with one-way ANOVA; comparisons among 
groups over time were accomplished using two- factor ANOVA. A repeated measures design 
requires that every participant participates in every condition of the experiment, historically 
called a within-subjects design. Our data was unbalanced, that is, there were slightly 
different but unequal sample sizes across each group since some procedures were not able 
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to be performed in each animal due to technical reasons (e.g., catheter malfunction). The 
repeated measures design drops sample sizes in the analysis until the same, or equal, 
numbers are in each group across all time points. Ideally the repeated measures design (with 
time point) would be preferred. However, this selection of analysis would drop the already 
small sample size until the numbers were equal across all time points and in each group 
observed – until they all have the same sample size. The two-factor approach (group and 
time point) allows us to keep all the data available and conduct mean comparisons, using a 
Sidak post	 hoc test for multiple pair-wise comparisons. Homogeneity of variance was 
checked and verified using Leven’s test. Comparisons of ultrasound parameters between 
Fru+HS and Fru+HS+T groups were done using Student’s unpaired t-test. Differences were 
deemed statistically significant when the P-value was less than 0.05.	
RESULTS	
Baseline body weight and heart weight of fructose-fed and glucose-fed rats with and 
without antioxidant supplementation were similar. Kidney weights were significantly 
greater in control fructose-fed rats on either normal or high salt diets. In +T-treated rats, 
mean kidney weights were also higher but the differences were only significant for the left 
kidneys since right kidney weights displayed greater variability (Table 1).  
Baseline SBP, DBP, MAP and heart rate were similar across all groups (Table 2.2). 
Baseline PP appeared to be greater in the Fru+HS group but this did not achieve significance 
(P = 0.16). SBP and MAP increased significantly after three weeks of high salt diet in fructose-
fed but not glucose-fed animals; supplementation with antioxidant prevented this increase 



















Glu+NS	 8 230 ± 8  327 ± 7 2.9 ± 0.1  2.9 ± 0.2 3.8 ± 0.8 
Glu+HS	 12 224 ± 5  329 ± 8 2.9 ± 0.1  2.9 ± 0.3 3.9 ± 0.5 
Fru+NS	 8 227 ± 7    330 ± 13 3.1 ± 0.1*  3.2 ± 0.3* 4.1 ± 0.7 
Fru+HS	 10 226 ± 5  313 ± 5   3.2 ± 0.1*  3.1 ± 0.3* 3.9 ± 0.4 
Tempol	
Glu+NS+T	 10 222 ± 5  332 ± 10  2.9 ± 0.1 2.9 ± 0.2 3.7 ± 0.4 
Glu+HS+T	    12 228 ± 8  329 ± 5  2.8 ± 0.1 2.9 ± 0.3 3.9 ± 0.4 
Fru+NS+T	 9 224 ± 6  329 ± 9   3.2 ± 0.1† 3.2 ± 0.2 3.7 ± 0.4 
Fru+HS+T	 9 222 ± 5  337 ± 14   3.1 ± 0.1† 3.1 ± 0.4 3.7 ± 0.4 
Glu+NS, 20% glucose+0.4% NaCl; Glu+HS, 20% glucose+4% NaCl; Fru+NS, 20% fructose+0.4% NaCl; Fru+HS, 
20% fructose+4% NaCl; +T, indicates addition of 15 mg/400g BW Tempol®; BW, body weight. Values are mean 




Group definitions as in Table 1. Values are mean ± SE. * P	< 0.05 vs Glu-NS; ‡ P	< 0.05 vs Fru-NS; † P	< 0.05 vs. 
Fru-HS. 
the groups. For clarity, Figure 2.2 depicts the progression of MAP over time only for fructose-
fed rats. By day 10, MAP rose significantly compared with baseline in Fru+HS rats and 
remained elevated from Day 17 through the 24th day. MAP progressively declined from Day 
7 to Day 24 in the Fru+HS+T group such that there was no difference in MAP among Fru+NS, 
Fru+NS+T and Fru+HS+T groups by day 24; however, MAP of the Fru+HS group was 
significantly greater than any of the other three groups.  SBP followed the same pattern as 
MAP. Glucose-fed rats in any of the groups did not display significant changes from baseline 
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or among the groups in MAP at any point of time (data not shown).  
 
Figure	2.1:	Change	in	mean	arterial	pressure	(MAP)	Timeline (over the 3-week period for the fructose-fed 
groups). Baseline MAP and delta MAP for glucose-fed groups did not change significantly over time (Table 2); 
not depicted graphically for simplicity. Fru+NS, 20% fructose+0.4% NaCl; Fru+HS, 20% fructose+4% NaCl; +T, 
indicates addition of 15 mg/400g BW Tempol; BW, body weight. * Values are mean ± SE; n as in Table 2. * P	< 
0.05 vs baseline for Fru+HS; † P	< 0.05 for Fru+HS vs all other fructose-fed groups by two-way ANOVA on Day 
24. 
Cardiovascular	parameters	measured	by	echocardiography	
The increase in MAP in the Fru+HS group was accompanied by an increase in aortic 
pulse wave velocity (PWV) (803 ± 19 mm/s, P < 0.005) compared with Glu+NS (606 ± 48 
mm/s), Glu+HS (645 ± 39 mm/s) or Fru+NS (700 ± 27 mm/s) groups (Figure 2.2A). 
Attenuation of free radical formation decreased aortic PWV in Fru+HS+T rats (686 ± 31 
mm/s, P < 0.005) compared to their non-treated counterparts (Figure 2B), while it produced 
no change in PWV in other groups (Glu+NS: 681 ± 30 mm/s, Glu+HS+T: 630 ± 37 mm/s and 
Fru+NS+T: 684 ± 43 mm/s). 
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Figure	2.2: Aortic	Pulse	Wave	Velocity (PWV) in (A) the four groups of rats: Glu+NS, 20% glucose+0.4% NaCl; 
Glu+HS, 20% glucose+4% NaCl; Fru+NS, 20% fructose+0.4% NaCl; Fru+HS, 20% fructose+4% NaCl. (B) Aortic 
pulse wave velocity in rats given either Fru+HS alone or with addition of 15 mg/400g BW Tempol (+T); BW, 
body weight, Fru+HS+T.  Values are mean ± SE; n as indicated per group; * P	< 0.005 vs other three groups; ** 
P	< 0.005 vs Fru+HS group.  	
Echocardiographic measures of systolic cardiac function revealed no overt phenotype 
in rats fed fructose and high salt diet. Ejection fraction, fractional shortening, left ventricle 
(LV) dimensions, and LV mass were similar across all groups (Table 2.3). Notably, only the 
Fru+HS rats displayed evidence of diastolic dysfunction (Figure 2.3). Specifically, the ratio of 
early (E) to late (A) transmitral filling velocities was decreased in Fru+HS rats (1.12 ± 0.03, 
P < 0.005) compared with the rats on glucose (Glu+NS: 1.28 ± 0.04 and Glu+HS: 1.37 ± 0.05) 
or Fru+NS rats (1.37 ± 0.08). Supplementation with the antioxidant did not change E/A in 
Fru+HS rats (1.09 ± 0.07) nor in any of the other groups: Glu+NS+T (1.38 ± 0.07), Glu+HS+T 
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(1.25 ± 0.06) and Fru+NS+T (1.28 ± 0.04).  
 
Figure	2.3: Ratio	of	Early	to	Late	(E/A)	Transmitral	Filling	Velocities.  In (A) the four groups of rats and 
(B) rats fed fructose-high salt alone or with Tempol (+T).  Group designations as in Figure 2. Values are mean 
± SE; n as indicated per group; * P	< 0.005 vs other three groups. 
The RRI, a measure of renal vascular stiffness or impedance, was significantly 
augmented in the Fru+HS group (0.60 ± 0.03, P < 0.05), compared with Glu+NS (0.45 ± 0.03), 
Glu+HS (0.45 ± 0.04) or Fru+NS groups (0.47 ± 0.05) (Figure 5A). No differences were 
observed among the +T-treated groups (Glu+NS+T, 0.50 ± 0.04; Glu+HS+T, 0.53 ± 0.4; 
Fru+NS+T, 0.50 ± 0.02; and Fru+HS+T, 0.60 ± 0.05). Notably, the antioxidant failed to reverse 
the augmented RRI in rats fed fructose and high salt diet (Figure 2.5B). 
Table	2.3:	Echocardiographic	Parameters	in	Control	Groups. 
Group definitions as in Table 1. LVEF, left ventricular ejection fraction; LVFS, left ventricular 
fractional shortening; HR, heart rate; LVAWs, left ventricular end-systolic wall thickness; LVAWd, 
left ventricular end-diastolic anterior all thickness; LVIDs, left ventricular end-systolic inner 
diameter; LVIDd, left ventricular end-diastolic inner diameter; LVPWs, end-systolic left 
ventricular posterior wall thickness; LVPWd, end-diastolic left ventricular posterior wall 
thickness. Values are mean ± SE. 
 Glu+NS		 Glu+HS	 Fru+NS	 Fru+HS	
N	 8 12 7 11 
LVEF	(%)	  82 ± 3 78 ± 3 85 ± 2 75 ± 3 
LVFS	(%)	 52 ± 3 48 ± 3 56 ± 3 47 ± 3 
LVAWs	(mm)	 3.11 ± 0.15 2.92 ± 0.12 3.31 ± 0.10  2.82 ± 0.09 
LVAWd	(mm)	 1.95 ± 0.06 1.98 ± 0.05 2.09 ± 0.09 1.85 ± 0.04 
LVIDs	(mm)	 3.07 ± 0.32 3.22 ± 0.22 2.72 ± 0.32 2.58 ± 0.21 
LVIDd	(mm)	 6.34 ± 0.19 6.34 ± 0.17 6.34 ± 0.27 6.58 ± 0.19 
LVPWs	(mm)	 2.94 ± 0.18 3.17 ± 0.16 2.92 ± 0.15 2.81 ± 0.19 
LVPWd	(mm)	 1.84 ± 0.09 1.96 ± 0.13 1.64 ± 0.14 1.84 ± 0.22 
















































































































Figure	2.4:	Elastic	Properties	 of	 the	Ascending	Aorta. Radial ascending aortic strain and distensibility 
coefficient, respectively, in the four groups of rats (A, C) and in rats fed fructose-high salt alone or with Tempol 
(B, D). Group designations as in Figure 2. Values are mean ± SE; n as indicated per group; * P	< 0.05 vs other 
control groups; ** P	< 0.05 vs Fru+HS group. 
The RRI, a measure of renal vascular stiffness or impedance, was significantly 
augmented in the Fru+HS group (0.60 ± 0.03, P < 0.05), compared with Glu+NS (0.45 ± 0.03), 
Glu+HS (0.45 ± 0.04) or Fru+NS groups (0.47 ± 0.05) (Figure 2.5A). No differences were 
observed among the +T-treated groups (Glu+NS+T, 0.50 ± 0.04; Glu+HS+T, 0.53 ± 0.4; 
Fru+NS+T, 0.50 ± 0.02; and Fru+HS+T, 0.60 ± 0.05). Notably, the antioxidant failed to reverse 

















Figure	2.5: Renal	Resistive	Index	(RRI). in (A) the four groups of rats and (B) rats fed fructose-high salt alone 
or with Tempol (+T).  Group designations as in Figure 2. Values are mean ± SE; n as indicated per group; * P	< 
0.05 vs other control groups; ** P	< 0.05 vs Fru+HS group. 
	
PRA,	angiotensin	II	and	insulin	levels	
High salt diet did not suppress PRA in either glucose-fed or fructose-fed rats (Table 
2.4). In contrast, plasma Ang II was significantly lower in both Glu+HS and Fru+HS rats 
compared with rats fed the same sugar on normal salt diet. Plasma Ang II was attenuated in 
both Glu+NS+T and Fru+NS+T groups such that there were no differences among any of the 
+T-treated groups. Although kidney cortical tissue Ang II tended to be higher in the +T-
treated normal salt groups vs the +T-treated high salt groups ingesting the same sugar, renal 
cortical tissue Ang II levels did not significantly differ among any of the groups. Non-fasting 
blood glucose values were similar among the groups (Table 2.4). Figure 2.6 shows that the 
glucose:insulin ratio was significantly diminished in the Fru+HS group (P < 0.05), indicative 
of insulin resistance compared with the other groups. The glucose:insulin ratio was restored 



















Glu+NS	 8 132 ± 2 4.7 ± 1.5 34.2 ± 4.6 1,609 ± 222 
Glu+HS	 12 134 ± 7 5.6 ±2.8 16.5 ± 4.2* 1,829 ± 269 
Fru+NS	 8 130 ± 5 5.6 ± 2.1 38.5 ± 5.8 1,667 ± 280 
Fru+HS	 10 137 ± 8 6.7 ± 2.8  22.2 ± 4.6‡ 1,403 ± 223 
	      
Glu+NS+T	 10 138 ± 6 4.9 ± 1.8 16.0 ± 2.3* 2,306 ± 396 
Glu+HS+T	 12    130 ± 4 5.1 ± 3.5 18.7 ± 4.3 1,376 ± 168 
Fru+NS+T	 9 142 ± 7 6.1 ± 3.0  25.4 ± 5.1  2,067 ± 241 
Fru+HS+T	 9 132 ± 3 5.3 ± 3.3 19.4 ± 3.5 1,509 ± 290 
Group definitions as in Table 1. PRA, plasma renin activity; Ang II, angiotensin II. Values are 




Figure	2.6: Glucose:insulin	Ratio (nM/nM x 106) in (A) the four groups of rats and (B) rats fed fructose-high 
salt alone or with Tempol (+T). Group designations as in Figure 2. Values are mean ± SE; n as indicated per 
group; * P	< 0.05 vs other control groups; ** P	< 0.05 vs Fru+HS group.  	
	
DISCUSSION	
The major findings of the present investigation support the hypothesis that fructose 
and high salt feeding for as short a period as three weeks in rats results in salt sensitive 
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systolic hypertension, stiffening of the ascending aorta, and diastolic left ventricular 
dysfunction. This occurs at a time when the rats have insulin resistance but are not frankly 
diabetic. Free radical scavenging at least partially reverses the aortic stiffening but not the 
diastolic dysfunction. The vascular perturbations associated with combined fructose and 
high salt intake include increased ascending aortic PWV, decreased radial ascending aortic 
strain, and an impaired distensibility coefficient. The decreased E/A ratio denotes early 
diastolic left ventricular dysfunction.  In addition, the increase in RRI in fructose-fed, high 
salt rats indicate impaired vascular compliance of the main renal artery that is not 
ameliorated by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, suggesting a mechanistic 
basis other than oxidative stress. Interestingly, although PRA is not suppressed, the 
vasoactive hormone plasma Ang II is reduced after three weeks of high salt diet in both 
glucose- and fructose-fed animals.  Intrarenal Ang II does not appear to be affected by either 
diet or antioxidant treatment.  
Fructose,	salt	and	blood	pressure	
The present studies confirm previous findings from our own [42] and other 
laboratories [41, 62, 66] showing that consumption of fructose at levels comparable to that 
ingested by the upper 20th percentile of the human population combined with high salt 
intake results in elevated arterial pressure. Although the increase in arterial pressure is 
modest when assessed in conscious unstressed rats by telemetry (vs tail cuff where in there 
is the additional stress component of mild restraint), it is nonetheless reproducible, 
significant, and sustained. Moreover, the present data indicate that the elevation in arterial 
pressure is primarily due to a disproportionate rise in systolic pressure which may be more 
closely related to large artery stiffness (see below). The combination of high fructose and 
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high salt intake has the potential to alter arterial wall cell function and structure independent 
of blood pressure [107, 108]. Hypertension, in turn, can influence vascular stiffness via 
cellular and structural responses to mechanical pressure-induced wall stress [109]. 
Regardless of whether systolic hypertension is a cause or effect of arterial stiffness [109].  
the result is a complex interplay of factors that are influenced by consumption of fructose 
and high salt diet. 
The observation that 4% NaCl diet does not suppress PRA in either glucose-fed or 
fructose-fed animals is distinctly different than the classic suppression of PRA by high salt 
diets in rats provided with normal carbohydrate diets [41, 110, 111]. Notably, earlier reports 
used higher salt diets (e.g., ≥8% NaCl) that do not reflect typical human intake to inhibit PRA 
and did not report plasma Ang II levels [112, 113].  Although high salt diet when ingested 
with fructose suppresses plasma Ang II but not renal tissue Ang II. The persistence of high 
intrarenal Ang II, which has been shown to increase proximal tubular sodium reabsorption 
[62, 114]. may very well be responsible for cumulative positive sodium balance and 
hypertension observed in this model [41].  Furthermore, dietary fructose augments Ang II-
stimulated superoxide formation by the kidney further enhancing proximal tubular sodium 
reabsorption and leading to volume-mediated hypertension [62, 111, 114]. Since antioxidant 
with +T treatment does not influence either plasma or intrarenal Ang II levels, it is more 
likely that its ability to decrease hypertension relates, at least in part, to its ability to decrease 
oxidative stress directly on the vasculature. More definitive data measuring vascular ROS 
and its products, which were beyond the scope of the present study, will be required to 





The axial heterogeneity of the aorta is well documented [115, 116]. For example, the 
ratio of elastic fibers to collagen changes from 3.1:1 in the ascending aorta to 2.8:1 in the 
thoracic aorta to 0.8:1 in the abdominal aorta [117]. Attenuation of the elastic properties of 
the proximal ascending aorta can have profound influence on end-systolic cardiac wall stress 
due to increased afterload, one of the most important factors in developing cardiac 
hypertrophy,[118] hence our choice to study the ascending aorta. In addition to the 
geometric properties of the left ventricle itself, aortic stiffness influences end-systolic cardiac 
wall stress [119]. Although there is no evidence of left ventricular hypertrophy, our 
echocardiographic studies were performed after only three weeks on the respective diets. 
Nevertheless, the reduced E/A ratio in the fructose-fed high salt rats reveals diastolic 
dysfunction which is the earliest indicator of hypertensive cardiac disease and precedes 
frank hypertrophy or systolic dysfunction [120]. Importantly, the diastolic impairment is 
significant despite the arterial pressure lowering effect of isoflurane anesthesia during the 
scan. Furthermore, inhibition of oxidative stress does not ameliorate this diastolic 
dysfunction despite lower arterial pressure suggesting involvement of alternative 
mechanisms.  
Ingestion of fructose plus high salt even, in the short-term, in the present study results 
in mildly elevated non-fasting blood glucose and a depressed glucose:insulin ratio consistent 
with insulin resistance similar to human pre-diabetes. Long-term studies have unequivocally 
demonstrated the development of left ventricular hypertrophy in metabolic syndrome;[121] 
however, even prolonged pre-diabetes provides a constellation of physiological 
derangements that favor left ventricular remodeling in rats [122, 123] and humans [124]. In 
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fact, fructose alone, albeit at a higher concentration (60%), causes cardiac hypertrophy in 
mice after 10 weeks [125]. Moreover, direct fructation of structural proteins [107] or 
alterations in sympathetic cardiac innervation [126] have been associated with diastolic 
dysfunction. Thus, despite the lack of frank left ventricular hypertrophy, the presence of a 
pre-diabetic state and insulin resistance is likely also contributing to the diastolic 
dysfunction in the fructose plus high salt group [127]. 
Impairment	of	aortic	and	renal	artery	compliance	
Diabetes[128, 129] and hypertension[130, 131] are each independently associated 
with increased PWV. The increased PWV along with diminished radial ascending aortic 
strain and distensibility coefficient in fructose salt-sensitive rats indicates that aortic 
compliance declines early with insulin resistance prior to overt diabetes. Greater aortic 
stiffness occurs with only modest (5-6 mmHg) elevations in systolic (and mean) arterial 
pressure in the fructose-fed high salt rats. Increases in PWV are typically associated greater 
pulse pressures. Although the change in pulse pressure was similar after three weeks of high 
salt, it is noteworthy that baseline pulse pressure in the fructose-fed high salt rats tended to 
be higher, albeit not statistically significant. Sympathetic innervation of the aorta is now 
recognized as a factor in aortic stiffening [132], and fructose-fed high salt rats display 
heightened renal sympathetic nerve activity. Renal denervation prevents the hypertension 
in this and other rodent models [42, 133] and ameliorates PWV in animal [133]  and human 
systolic hypertension [134]. The contribution of cellular metabolic changes or ion-induced 
contractility cannot be totally excluded since triglycerides and cumulative salt balance are 
elevated in this model [41]. Thus, aortic stiffness is only partially dependent of blood 
pressure and may also be influenced by biophysical changes in the structure and/or function 
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of the arterial wall evoked by fructose plus high salt diet.  
Increased oxidative stress has been implicated in decreased aortic compliance in 
disease [135] as well as normal aging [136, 137]. The agent, 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl, is a nonselective superoxide dismutase mimetic that reduces 
free radical formation and peroxynitrite formation, thereby limiting inflammation. Similar 
to findings with free radical scavenging in aging mice [138], our results indicate that 
attenuation of oxidative stress in fructose salt-sensitive rats rescues some aspects of elastic 
properties of the aorta, restoring normal PWV and radial ascending aortic strain.  
Like the aorta, renal artery compliance is reduced which is reflected by the elevated 
RRI in fructose-fed high salt rats. In contrast to the ascending aorta, renal artery stiffness 
does not improve after treatment with this antioxidant. Although 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl has been shown to decrease renal superoxide anion and 
improve renal vascular resistance via a nitric oxide dependent mechanism,[111, 139] RRI 
tracks more closely with systemic vascular parameters, intrinsic renal artery compliance and 
pulsatility than with intrarenal vascular resistance [98]. This is not to say that this 
heightened pulsatility is not transmitted distally thereby ultimately resulting in 
hypertensive nephropathy and chronic kidney disease. 
While the present hemodynamic measurements have been performed in conscious, 
freely moving rats, ultrasonography necessitates isoflurane anesthesia. Importantly, 
isoflurane anesthesia does not alter measures of arterial stiffness [140]. 
CONCLUSION	
The rodent model used in these studies was chosen to mimic the amount of fructose 
and salt ingested by the upper fifth of the western population. Notably, impaired vascular 
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compliance of the proximal ascending aorta and renal artery occur after only short-term 
exposure to the fructose-high salt diet when insulin resistance but not frank hyperglycemia 
and only mild, but significantly elevated blood pressure occur. The loss of vascular 
compliance results in transmission of the elevated pressure wave downstream and may, 
thereby, predispose to hypertensive organ damage including nephrosclerosis.  The presence 
of left ventricular diastolic dysfunction with preserved systolic function strongly suggests 
that   that a diet of fructose combined with high salt exerts an independent effect on left 
ventricular relaxation. Importantly, antioxidant treatment normalizes fructose-induced salt 
sensitive hypertension and mitigates increase in aortic pulse wave velocity. These data, 
therefore, cannot distinguish whether at aortic compliance is directly altered by reactive 
oxygen species induced by the high fructose plus high salt diet or indirectly via the elevation 
in arterial pressure or both. In contrast, left ventricular diastolic dysfunction and renal artery 
compliance are not altered by the free radical scavenger despite the decrease in blood 
pressure indicating that alternative mechanisms are responsible. Taken together, these 
findings indicate that a diet high in fructose and salt may lead to subtle, possibly progressive, 
pathophysiologic changes in the central cardiovascular system well before frank clinical 
disease is apparent. Changes in nutritional behavior and early assessment are imperative to 







Environmental and lifestyle factors such as diet have become important contributors 
to the increasing prevalence of hypertension. The increase in hypertension has occurred 
concurrently with the rise in consumption of fructose-sweetened products [12, 141, 142]. 
Likewise, sodium consumption has remained high and is directly correlated to numerous 
cardiovascular and renal diseases [143, 144]. Recent research has shown that a diet high in 
fructose induces a state of increased sodium retention that leads to hypertension. Onset of 
this disease state occurs well before the development of metabolic syndrome or frank 
diabetes mellitus [41, 42]. Adolescents and young adults, particularly those from lower 
income levels, are the group  consuming of the highest amounts of fructose, which is sourced 
predominately through sugar-sweetened beverages [12]. Despite this disparity, there are 
few studies investigating the chronic effects of these dietary regimens in youth and the 
potential impact later in life.  
Particularly with polygenic disorders such as hypertension, full phenotypic 
manifestation does not generally occur before adulthood. The insults that shape disease 
progression and extent can often be traced back to early periods of development, or 
ontogeny [145]. The development of organs and physiologic systems can be attributed to 
specific time points; chiefly the earliest developmental stages of these systems are marked 
by the most rapid growth. During these windows of development, application of external 
stimuli can exert influence that can alter physical and mechanistic organ properties. These 
windows or time frames are referred to as critical developmental periods. While time frames 
vary and are approximate, readjustment of central hemodynamics in response to post-natal 
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growth occurs during prepuberty and sexual maturation, which occur between 4 and 6 
weeks after birth [146-148]. Readjustment occurs predominately via morphogenesis, 
however additional maturation of pressor governing systems such as the baroreflex and 
renin-angiotensin-aldosterone-system (RAS) are simultaneously occurring [149-152]. 
In several preclinical models, a high salt diet in early life stages induces salt-sensitive 
hypertension that may not necessarily occur when the same challenge is applied in 
adulthood [153-156]. Likewise, various transient anti-hypertensive therapies applied in 
adolescence attenuate the development and degree of hypertension in genetically 
predisposed strains [157-159]. Notably, this effect coincides with the same critical time (4-
9 weeks of age) periods used in salt-sensitivity programming via excess sodium loading, 
further indicating the importance of these time periods in hypertension induction. 
The impact of fructose programming in neonates and adolescents is less well 
understood. GLUT5 is a glucose transporter that specifically transports fructose and is 
considered critical to the development of fructose induced salt-sensitive hypertension [160]. 
It is under-expressed in neonatal intestinal tissue. After weaning there is an abrupt increase 
in protein and mRNA expression, however, and these patterns can be enhanced if fructose is 
provided during weaning [161, 162]. Whereas cessation of fructose feeding is marked by 
restoration of fructose transport systems to control levels, the induction or maintenance of 
these transport mechanisms could conceivably lead to the development of salt-sensitivity 
and hypertension at a young age and beyond. Based on the observed effects of sodium 
programming in youth, it is possible that exposure to fructose early in life will exert long 
term effects. Thus, we hypothesize that a diet high in both fructose and salt, but not high in 





Since previous reports were almost exclusively performed in male rats, our studies 
were performed in male rats to permit assessment of the impact of fructose in the context of 
existing studies. Male Sprague Dawley rats (Envigo Sprague Dawley, Shelby, MI) were 
housed under controlled conditions (21–23°C; 12-hr light/ dark cycles, lighting period 6 AM 
to 6 PM). Complete care provided to rats was in accordance with the principles of the 
National Institutes of Health Guide	for	the	Care	and	Use	of	Laboratory	Animals. All procedures 
and protocols were approved by the Wayne State University Institutional Animal Care and 
Use Committee (Protocol #19-03-1001).  
Dietary	regimen	
 Upon arrival, rats were acclimated in standard polyurethane caging and were 
permitted ad	libitum access to water and standard rat chow for a minimum of 48 hours prior 
to enrollment in the experimental protocols. At the age of 4-5 weeks (body weight ~125 g), 
rats underwent placement of a hemodynamic telemetry transmitters and recovered in single 
housing for 3-5 days. Following recovery, rats were placed into metabolic housing units 
(Tecniplast USA, West Chester, PA) and randomly fed chow containing either 20% fructose 
or 20% glucose with 0.4% sodium. These diets were provided ad	 libitum for 5-7 days to 
permit baseline hemodynamic recordings. Then, the rats were formally entered into the 
phases of the protocol (Figure 3.1). 
Phase I (Days 0 – 22±2): Rats were assigned to chow containing 20% glucose and 
0.4% sodium group (glucose low sodium - GLS; ModTest Diet® 5755 – 5WZZ; n = 10); 20% 
























































































































































































































































or 20% fructose and 4.0% sodium (fructose high sodium - FHS; ModTest Diet® 5755 – 5WZ8; 
n = 18) for 3 weeks.  Rats were pair-fed indexed to overall caloric intake due to account for 
differences in energy profiles (kcal/g) among the dietary formulations. Water provision in 
all groups remained ad	libitum throughout the study.  
Phase II (Days 23 – 44±2): The rats were returned to singly housed, polyurethane 
cages in which food and water were provided ad	libitum. All rats on the GLS and FLS diets 
and 50% of the rats on the FHS diet were placed on the GLS diet. The remainder of the FHS 
rats remained on the FHS diet.  
Phase III (Days 45 – 66±2):  Rats were returned to metabolic housing units after three 
weeks and were permitted a three-day acclimation period. Rats fed fructose in Phase I were 
subjected to a high salt challenge with 20% glucose and 4.0% sodium (glucose high sodium 
- GHS; ModTest Diet® 5755 – 5WOW). As a control, the GLS group from Phase I remained on 
GLS diet. This resulted in four overall groups:   1) GLS-GLS, 2) FLS-GHS, 3) FHS-GHS, and 4) 
FHS-FHS. This regimen was continued for an additional three weeks at which time terminal 
studies were conducted.  
Surgical	procedures	
Hemodynamic Telemetry Transmitter Placement.  All surgical procedures were 
conducted under intraperitoneal ketamine (80 mg/kg; Mylan Institutional, LLC Rockford, IL) 
and AnaSed/xylazine (10 mg/kg; Akorn Animal Health, Inc., Lake Forest, IL) anesthesia and 
subcutaneous administration of buprenorphine SR (0.3 mg/kg) for analgesia. For 
hemodynamic telemetry unit placement, an inguinal incision was made, and the right 
femoral artery was exposed. Permanent ligation of the distal artery was placed using 3-0 silk 
suture while a proximal segment of the vessel was temporarily occluded using a vascular 
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clamp. A small arterial incision was made and the gel-filled catheter of the hemodynamic 
transmitter (HDS-10, Data Sciences International, MN) was inserted into the vessel using a 
21-gauge needle as a guide. The vascular clamp was then removed and the catheter advanced 
into the abdominal aorta. The transmitter body was subcutaneously tunneled dorsally to the 
right flank and the incision was closed using surgical staples.  
Vascular Catheter Placement. At the end of Phase III, catheters were placed into the 
left carotid artery and external jugular vein using anesthetic and analgesic regimen above as 
previously performed in our laboratory [42, 163]. Catheters were anchored using 3-0 silk 
suture, tunneled subcutaneously, and exteriorized between the scapulae. All incisions were 
closed using 4-0 Prolene suture (Ethicon, Johnson & Johnson, New Brunswick, NJ). The 
catheters were filled with heparinized saline (1000 units/mL) and secured. The rats were 
then permitted to recover in individual standard cages. 
Analytical	measurements	and	calculations	
Telemetry. Acquisition of hemodynamic data was conducted using Ponemah software 
(Data Sciences International, MN). Measurement of systolic blood pressure (SBP), diastolic 
blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were sampled for 
10 seconds every 4 minutes at a sampling rate of 500 samples/second. Pulse pressure (PP) 
was calculated separately using these values. Baseline measurements were averaged over 
three days following a three-day cage acclimation. Sampling was performed at this rate 
continuously throughout each study phase within metabolic cages. 
Metabolic Assessment. Water intake, chow consumption, and urine volume were 
measured gravimetrically. Urinary sodium and potassium were measured via flame 
photometry using an internal lithium standard (Cole Parmer Instruments, Verner Hill, IL).  
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Transcutaneous Assessment of Renal Function. Glomerular filtration rate (GFR) was 
assessed at the end of each phase (Figure 3.1)  using venous bolus injections of fluorescein-
isothiocyanate-(FITC)-sinistrin as described by Schock-Kusch et	al	[164]. Rats were briefly 
anesthetized with isoflurane and a small adhesive patch with an LED-emitting optical 
transducer (Mannheim Pharma and Diagnostics GmbH, Mannheim, Germany) was placed on 
a shaved region on the dorsal aspect of the thorax. Baseline measurements were recorded 
for 3-5 minutes, thereafter a single bolus injection of FITC-sinistrin, 6 mg/100 g BW 
(Fresenius-Kabi, Linz, Austria) was administered via tail vein (Phases I and II) or venous 
catheter (Phase III). Rats were recovered in singly housed polyurethane cages and 
measurements were recorded for 2 hr. FITC-sinistrin disappearance kinetics were analyzed 
via a 3-compartment approach using MB Studio software (Mannheim Pharma and 
Diagnostics GmbH, Mannheim, Germany). GFR was calculated using the following formula: 
[22]           GFR[ml/min/100g BW] = 31.26[ml/100gBW]                   
t1/2(FITC−sinistrin)[min] 
Terminal Procedures and Hormonal Assessment. Following the GFR assessment after 
Phase III, the rats were permitted a 6-8 hour recovery period with no access to food before 
terminal harvest. Blood was collected from conscious rats via the carotid arterial catheter 
into pre-chilled tubes for hormonal analysis. Fasting glucose levels were determined using a 
One-Touch Ultra glucose monitor (LifeScan, Inc., Malpitas, CA). For plasma renin activity 
(PRA) assay, 1 mL of blood was collected into a tube containing 50 μL sodium 
ethylenediaminetetraacetic acid (EDTA). Blood (2 ml) was collected into a separate tube 
containing 120 μL of 500 mM sodium EDTA, 125 mM phenanthroline, 1 mM 
phenylmethanesulfonyl fluoride, 20 mM pepstatin, 1 mM enalapril and 10X phosphatase 
inhibitor cocktail for insulin assessment. Once collected, blood was immediately centrifuged 
43 
 
at 3000 rpm for 4 minutes at 4°C. Plasma was stored at -70°C until assayed.  
Rats were then euthanized with sodium pentobarbital (120 mg/kg, iv). Kidneys were 
harvested, kept at 0°C in saline, and weighed. A segment of renal cortex was excised and 
stored at -70°C. A slice of kidney tissue was placed into formalin for 48 hr and paraffin 
embedded for histological analysis for future studies.   
Statistical analysis. Between-group differences in the pattern of change over the study 
design were tested in a repeated-measure ANOVA framework, interpreting multivariate 
statistics as a profile analysis of longitudinal change. Consistent with the experimental 
design, hypothesis tests were conducted for Phase 1 and Phase 3 separately, without need 
for multiple comparison correction between phases in variable timeline assessments. Based 
on initial visual evaluation, the trajectories of daily change appeared non-linear, and an 
analytic approach was taken in which hypotheses were tested separately for Weeks 1 – 3 of 
each Phase. Type I error rate was controlled across the multiple tests by week with a 
Bonferroni correction for three comparisons (α’ = 0.02). Missing data points in daily 
measurements were adjusted for by substituting overall phase group means. Group sizes 
may among variables due to anatomic and or technical issues that precluded assessments of 
some measurements.  
RESULTS	
Acute	and	chronic	hemodynamic	effects	of	diet	in	adolescence.	The addition of high salt 
to fructose fed rats led to a progressive increase in mean arterial pressure that was 
significantly elevated after four days (Figure 3.2). This increase was maintained for an 
additional two weeks before becoming statistically comparable to other groups at the end of 
Phase I. Whereas groups did not differ in Phase I final MAP levels, the overall change between 
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final and baseline values of Phase I in FHS groups was statistically greater than that of other 
groups (p<0.01). Throughout Phases II and III, FHS feeding led to a continuously increasing 
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Figure	3.2:	Timeline	of	Daily	Mean	Arterial	Pressure. Measurements calculated as the average of 24 hour 
daily intervals. Measurements acquired from a catheter implanted into the abdominal aorta. Values are 




In phase III, mean arterial pressure significantly increased over the first week (p < 
0.001) and the pattern of change differed among groups (P = 0.001): FHS-FHS and FLS-GHS 
demonstrated moderate increase, as compared to a relatively smaller increase in FHS-GHS, 
and stability of GLS-GLS. With one-way ANOVA to examine the specific group differences at 
Day 1 and Day 7, groups were overall equivalent at the start of Phase 3 (P = 0.11) but within 
a week group differences emerged (P = 0.001) following apparent elevation in FLS-GHS and 
FHS-FHS. Subsequent change over week 2 was also different among groups (P	= 0.015) and 
by Day 14, FLS-GHS stabilized to average levels consistent with FHS-FHS (P = 0.79) and FHS-
GHS (P = 0.60).  
Table	3.1: Study‐wide	Changes	in	Hemodynamics. 
Calculated as the difference between measurements taken at the end of Phase III and the baseline 
measurements taken at the beginning of Phase I. Values are indicated as mean ± SE, N as indicated per group; 
*P <0.05 vs. GLS-GLS controls. **P <0.01 vs. GLS-GLS controls. 
Study-wide analysis (Table 3.1) evaluating the overall change in hemodynamic 
parameters throughout the entirety of the study indicated comparable increases between 
FLS-GHS and FHS-GHS groups that were significantly elevated above GLS-GLS controls 
(P<0.05). The increases in FHS-FHS controls were elevated above this when compared to 
controls (P<0.01). Overall study changes in SBP followed similar trends as MAP, but DBP and 
heart rate did not. While the change in DBP was not significant it increased sufficiently to 


















GLS‐GLS	 7 10.0±1.0 11±2.2 11±1.2 -92±11 2.4±1.5 
FLS‐GHS	 8 15±0.9* 18±0.9* 14±1.3 -103±18 4.2±1.6 
FHS‐GHS 8 15±1.4* 18±1.7* 13±1.7 -105±6 4.2±2.0 
FHS‐FHS	 8   16±2.0**   19±2.3** 14±1.9 -89±14 4.6±1.4 
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Acute	and	 chronic	metabolic	profiles	of	 fructose	and	high	 salt	programming	during	
adolescence.	 Except during the initial baseline recordings, all rats in metabolic cages in 
Phases I and III were placed on a pair feeding paradigm. Chow consumption was assessed 
daily, and the amount provided was determined by caloric consumption, rather than direct 
gravimetric assessment. This protocol design was implemented as a more accurate 
correction to limit differences in total nutritional consumption due to the varying energy 
profiles (caloric content) of each type of chow. Statistical differences between caloric intake 
were observable initially following dietary changes to high salt feeds in both glucose and 
fructose groups in both Phases I and III, but these gradually normalized among groups. High 
Na+ intake was accompanied by increased fluid intake and urine excretion, both of which 
reached a maximum by the end of week 2 in Phases I and III (Table 3.2).  
As defined in Methods, high and low salt feeds were comprised of 4.0% Na+ and 0.4% 
Na+, respectively. Consistent with a pair feeding strategy, low salt fed rats consumed 
approximately 10% of the amount of sodium consumed by high salt fed rats (Table 3.3). This 
increase in dietary sodium intake was accompanied by increases in both urine production 
and Na+ excretion. Albeit, sodium excretion was significantly increased compared to low salt 
diets, it was insufficient in maintaining a neutral bodily sodium balance. Net (Figure 3.3A&B) 
and cumulative (Figure 3.3C&D) Na+ balances are depicted in Figure 3.3. Phase I net Na+ 
balances changed over week 1 (P < 0.001) and groups differed in the pattern of change (P	< 
0.001): FHS-FHS and FLS-GHS both show faster increase over the initial 7 days of Phase I as 
compared to stable low levels of GLS-GLS and stable high levels of FHS-GHS. Over this period, 
groups differed on average (P< 0.001): GLS-GLS had a lower net Na+ balance as compared 
with all other groups (all P < 0.001), and FHS-GHS greater than FHS-FHS (P = 0.04). Between 
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group differences were only evident in week 1, and net Na+ did not change over week 2 (P = 
0.36) or week 3 (P = 0.09). GLS-GLS remained significantly lower than all other groups over 




Recorded at 5 PM each day. Caloric intake calculated using caloric profiles of 3.98 kcal/g and 3.61 kcal/g for 
low salt and high salt feed, respectively. Values are indicated as mean ± SE, N as indicated per group; *p<0.05 








Measurements obtained via flame photometry analysis of urine samples collected daily. Values are indicated 





High and low salt feeds were comprised of 4.0% Na+ and 0.4% Na+, respectively. 
Consistent with a pair feeding strategy, low salt fed rats consumed approximately 10% of 
the amount of Na+ consumed by high salt fed rats (Table 3.3). This increase in dietary sodium 
intake was accompanied by increases in both urine production and sodium excretion. 
Although sodium excretion was significantly increased compared to low salt diets, it was 
insufficient in maintaining a neutral bodily Na+ balance. Balances are expressed in terms of 
net and cumulative Na+ balances in Figure 3.3.  
Observed net Na+ balance in FHS rats in Phase I significantly increased from baseline 
to day 8 (p< 0.001), continued to change across week 2 (P= 0.003), but normalized by week 
3 (P = 0.25). This trend was reflected by a continuously and significantly increasing 
cumulative balance throughout weeks 1-3 following baseline (P	< 0.01). Phase III net Na+ 
balances changed over week 1 (p < 0.001) and groups differed in the pattern of change (p	< 
0.001): FHS-GHS and FLS-GHS both show faster increase over 7 days as compared to stable 
low levels of GLS-GLS and stable high levels of FHS-FHS. Over this period, groups differed on 
average (p < 0.001): GLS-GLS had a lower net Na+ balance as compared to all other groups 
(all p < 0.001), and FHS-GHS greater than FHS-FHS (p = 0.04). Between group differences 
were only evident in week 1, and net Na+ did not change over week 2 (p = 0.36) or week 3 (p 
= 0.09). GLS-GLS remained significantly lower than all other groups over week 2 (p < 0.001) 








Figure	3.3:	Bodily	Sodium	Balance. Measurements obtained via flame photometry analysis of urine samples 
collected daily. Values are indicated as mean ± SE, N as indicated per group. A.) Phase I net sodium balances -
*p<0.05 vs. GLS-GLS controls. B.) Phase I Cumulative Sodium Balance - *p<0.05 for rate and absolute values vs 
GLS. C.) Phase III Net Sodium Balances - *p<0.05 FHS-GHS and FHS-FHS vs. GLS-GLS controls, Ωp<0.05 FLS-GHS 
vs. GLS-GLS. Phase I Cumulative Sodium Balance - *p<0.05 for rate and absolute values vs GLS. D.) Phase III 
Cumulative Sodium Balance - *p<0.05 for absolute values of FHS-GHS vs. FHS-FHS. 
Cumulative sodium balance increased all but GLS-GLS groups during Phase III: (P< 
0.001), week 1-3 respectively.  Groups differed in the magnitude of change across all weeks 
(P	< 0.001). The group and day interaction was driven by GLS-GLS remaining stable while all 
other groups increased. A pattern of between-group differences emerged over the three 
weeks (P < 0.001), with all groups equivalent at week 1 and week 2 (except GLS-GLS, P	< 
0.01) and FHS-GHS observed with higher cumulative sodium balance than FHS-FHS (P < 
0.03) by week 3. This effect by the last week appears to be due to a slight elevation at Day 1 
and not necessarily a meaningfully different rate of increase; although the group difference 
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to start was small and not statistically significant, the meaningful effect in FHS-GHS emerged 
over time as a compounding effect in cumulative Na+ balance.	
Table	3.4:	Metabolic,	Renal,	and	Endocrine	Measurements. 
Assay values conducted using blood samples collected through an intra-arterial line extracted under conscious 
conditions. Rats were fasted for a minimum of 6 hours prior to collection. Values are indicated as mean ± SE, N 
as indicated per group; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS controls Due to technical 
complications, G:I (Glucose:Insulin) ratio N values differ and are as follows: GLS-GLS -5 , FLS-GHS - 6, FHS-GHS 
- 7, FHS-FHS - 7. 
Chronic	 effects	 on	 metabolism,	 endocrine	 systems,	 and	 renal	 function.	 Table 3.5 
represents primary findings from terminal procedures. One-way ANOVA of final body 
weights did not find significant variance amongst groups, although the FLS-GHS group 
differed significantly from GLS-GLS controls. Likewise, there were no significant differences 
between right and left kidney weights. However, normalization to body weight found 
increased weight of both kidneys in FLS-GHS and FHS-FHS.  
No significant differences in fasting plasma glucose levels were found among groups, 
and these levels did not vary from vendor specifications for Envigo® bred Sprague-Dawley 
rats. Plasma insulin levels indicated a reduced level of fasting insulin compared to other 
groups, but this was insufficient in producing any statistical trend when analyzed by ANOVA 
(data not shown). A glucose:insulin ratio was chosen as a measure of insulin sensitivity given 
our inability to perform overnight fasting for HOMA measurements of insulin resistance (due 

























GLS‐GLS	 9 125±4 380±27 3.3±0.3 3.2±0.2 128±13 64.7±6.4 1.82±0.20 
FLS‐GHS	 9 132±4 346.7±30 3.7±0.4* 3.5±0.4* 129±24 74.6±12.6* 0.66±0.12** 
FHS‐GHS	 8 128±3 362.2±33 3.5±0.3 3.4±0.2 126±14 31.6±1.9 1.35±0.28 
FHS‐FHS	 9 127±5 365.8±36 3.7±0.3* 3.7±0.2* 118±11 43.0±8.3 1.09±0.29* 
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conducted by our laboratory [42, 163]. The reduced insulin levels in FLS-GHS rats drove the 
significance in this group upon ANOVA analysis of G:I ratio. All other groups remained 
statistically similar. This decline was associated with a reduction in weight and caloric 
consumption in this group at the time of conversion to a high salt diet in Phase III.  
Assessment of glomerular filtration rate (Figure 3.4) found no difference among 
groups at the end of Phase I and Phase II, with little change within each group between 
phases. GLS-GLS fed rats showed no significant differences over time. Conversely, FHS-FHS 
groups experienced a significant decline in GFR. Phase III was particularly characterized by 
this reduction in the FHS-FHS group. Reductions in GFR in this group were significant when 
compared to GLS-GLS in Phase I and Phase III, as well as in pairwise analysis of FHS-FHS 
changes over time. Whereas FHS-GHS did not significantly decline in Phase III compared to 
GLS-GLS rats, groupwise changes over time were significant. FLS-GHS fed rats followed a 
similar trend over time, but this did not achieve statistical significance. The reduction in GFR 
in the FLS-GHS group, chiefly between Phases II and III, is considered a product of 
tubuloglomerular feedback in response to the recent high salt challenge and increasing 
arterial pressure. In contrast, functional reductions in FHS-GHS and FHS-FHS groups are 





























































































Figure	3.4: Assessment	of	Glomerular	Filtration	Rate.	Measurements obtained at the end of each phase. 
Phase I measurements were obtained after randomization into final group assignments, permitting assessment 
of all 4 groups. N values per phase are demonstrated graphically.  Values are indicated as mean ± SE; *p<0.05 
vs. GLS-GLS controls, Ωp<0.05 vs initial Phase I measurements for the same group assessed via two-way ANOVA. 
DISCUSSION	
The present study provides support that high dietary fructose and sodium 
consumption patterns can induce hypertension in adolescence with chronic effects 
manifesting in later life when challenged only with high salt intake. The physiologic changes 
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that occur during these developmental periods have lasting effects that can render the body 
susceptible to hypertensive stimuli later in life. Hypertension induction in adult rat models 
via high salt loading alone would require prolonged periods of feeding, making the model 
unappealing due to economic and logistical constraints. These time periods would extend 
beyond the relatively brief periods critical to ontogenetic programming of hypertension. 
Indeed, the induction of hypertension in early life using high salt in rat models cannot, to our 
knowledge, be accomplished without additional manipulations that render the body more 
susceptible to the influence of sodium. Such manipulations include surgical deformation, 
either breeding or direct induction of genetic predispositions, chemical treatment (i.e. 
deoxycorticosterone-acetate), or severe metabolic disturbances [165-170]. Diets rich in 
fructose and sodium are immersed into western culture throughout all periods of life. The 
propensity for higher daily ingestion of fructose and salt in adolescents and young adults 
provides a strong basis for rigorous evaluation of the impact on subsequent cardiovascular 
and renal function and the relevance of this study.  
The increases in arterial pressure in this model of fructose-induced salt-sensitive 
hypertension have been observed in several other studies [41, 42, 66]. These studies 
however used methods of blood pressure measurements that made discernment of 
individual contributions of each hemodynamic component difficult. In this study, chronic 
telemetry-based recording enabled a well-defined examination of BP changes over time. 
Analysis of change throughout the entire study unveiled significant increases in MAP in FLS-
GHS, FHS-GHS, and FHS-FHS groups. Significant increases in systolic blood pressure were 
observed with no significant change in DBP occurred, indicating the increase in MAP was 
driven by systolic mechanisms.  
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The greatest increases in BP throughout the study were observed in the chronically 
fed FHS group, but values were only significantly elevated in Phase I and then proceeded to 
gradually increase throughout the remainder of the study. Significant increases in MAP that 
occur in any group throughout the study consistently coincide with the dietary addition of 
high salt. FHS-GHS groups experienced a significant increase in Phase I with a secondary 
increase when challenged with the addition of high salt in Phase III. BP patterns in the FLS-
GHS group followed those of the GLS-GLS controls until Phase III, which was characterized 
by the most significant increase among all groups when given high salt. With regards to 
hemodynamic changes, the dietary addition of fructose during weeks 5 to 7 is as important 
in the development of susceptibility to salt sensitive hypertension later in life as sodium is 
itself.  
Prior in	vivo	and ex	vivo	studies in adult rats have shown that both short term and 
chronic feeding, or acute perfusion of fructose increases activity and expression of fructose, 
sodium, and chloride transport systems within across the intestinal and renal epithelium. 
The osmotic gradient that develops in the intestine is important for absorption and initial 
increases of extracellular volume while the reabsorption mechanisms within the kidney 
serve to maintain and even potentiate this effect [40, 60, 160, 171-173]. Rats fed a FHS (both 
FHS-FHS and FHS-GHS groups) diet in Phase I had a significant increase in net sodium 
balance during Phase III, calculated as the difference between sodium consumption and 
urinary excretion. This was accompanied by an increase in net fluid balance, indicating 
increased fluid retention.  
These trends follow those of similar studies using DOCA to induce salt-sensitive 
hypertension. Treatments initiated during early critical developmental periods elicited 
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robust increases in extracellular volume and arterial pressure  that were not observable 
when treatments were initiated in adulthood [174]. Chronic increases in extracellular 
volume cannot perpetually drive increasing arterial pressure, however, as this would 
ultimately prove fatal. Pressure natriuresis in each high salt fed group was sufficient to 
prevent further increases in arterial pressure but unable to restore them to normotensive 
levels, potentially indicating baroreceptor resetting at central and renal levels.  
The maintenance in post-pubertal arterial pressure indicates additional mechanisms 
in place, many of which have been investigated in other studies. Changes in autonomic 
activity that can modulate physiologic function both locally and regionally have been 
implicated with high salt, with and without the addition of dietary fructose [175]. This may 
serve to increase total peripheral resistance, cardiac function, or directly influence the RAS 
[176]. Indeed, renal sympathetic activity is increased in adult rats fed a fructose and high salt 
diet and stimulates renin secretion [42]. Thus, suppression of PRA by increased blood 
pressure and extracellular volume may be counteracted by enhanced sympathetic input to 
the kidney. Consistent with such a mechanism, the FLS-GHS group had the greatest extent of 
renin suppression (indicated by reduced PRA). In contrast, early exposure to FHS in the FHS-
GHS and the FHS-FHS groups prevented suppression of PRA later in life. . Contrastingly, no 
reduction in PRA in FHS-GHS groups compared to GLS-GLS controls was observed which 
likely played a consequential role in the increased sodium reabsorption in Phase III and the 
elevated arterial pressure. Altered renal sympathetic activity and resetting renal 
autoregulatory mechanisms may be implicated in this but were not the focus the study [177-
179]. Additionally, our laboratory has shown that reactive oxygen species has are also 
implicated in fructose and high salt diets. Oxidative stress can further induce vaso-
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dysfunction, tubule sodium reabsorption, and renin secretion  [180-183].  
Perspectives	
These mechanisms provide insight into the observed effects of the FHS-FHS and FHS-
GHS groups in Phase III, all of which were likely exaggerated by ontogenetic programming 
[184]. Previous studies have demonstrated that high salt or even glucose combined with high 
salt does not increase net sodium balance in and of itself, nor does it have any significant 
impact on arterial pressure [41, 42, 163]. The present study found that a priming period of 
solely fructose feeding was necessary to promote a state of salt-sensitivity capable of 
eliciting increases in blood pressure following high salt challenge in the absence of fructose 
later in life. While alternative mechanisms acting to increase blood pressure such as 
increased sympathetic activity – regional or peripheral – or vascular dysfunction cannot be 
disregarded, the central role of the kidney in this model cannot be understated. Renal 
reabsorption of sodium plays an essential role in the development of hypertension in 
adolescence and the prolonged salt-sensitivity well into adulthood, despite the restoration 
of non-pressor inducing diets.  
In light of research into protein and mRNA expression patterns of the relative sodium 
and fructose transport systems during fructose feeding, this period likely reflects a 
developmental, transport aggregational state. Singh et	al.	showed that within two weeks of 
fructose feeding, mRNA and protein abundance of intestinal transporters such as PAT1, 
GLUT5, NHE3 substantially increased and remained elevated with prolonged fructose 
feeding [160]. Similar patterns are observable within the kidney through post-translational 
and post-transcriptional mechanisms [172]. As discussed above, GLUT5 expression can be 
manipulated if fructose is provided to weanling rats, and this programming would likely 
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serve to amplify the already dramatic expression increases occurring in the presence of 
fructose. To our knowledge, expression of these transport systems has not been investigated 
following the cessation of fructose feeding. The extent and time length these transporters 
remain expressed would provide pathologic insights into the robust salt-sensitivity response 













The prevalence of hypertension has been increasing in the United States both 
independently and concurrently with the rise of diabetes throughout the past several 
decades. Elevated fructose consumption has been implicated in metabolic disorders and 
subsequent cardiovascular morbidity [12, 13, 32]. In most pre-clinical models, high levels - 
often exceeding 60% of daily caloric intake - of fructose consumption elicit hypertension and 
cardiovascular dysfunction, and implicate insulin signaling as the pathogenic mechanism 
[31, 32]. Ingestion of 20% fructose in drinking water together with a high salt diet, levels 
comparable to the diet ingested by the upper quintile in humans, results in sodium and fluid 
retention in rats, leading to a hypertensive state prior to development of frank metabolic 
syndrome or diabetes [41, 42].  
Adolescence is marked by the continuous development and growth of physiologic 
systems. Particularly in earlier stages of life, various systems undergo substantial 
developmental changes and are susceptible to modulation by external stimuli. While there 
are several studies on the effect of fructose consumption on cardiorenal systems in adults, 
little is understood regarding the impact of diets rich in fructose alone on development 
during adolescence [77]. Notably, western diets use high fructose corn syrup extensively as 
a sweetener and are also high in sodium content [13]. In this regard the largest consumers 
of fructose are adolescents and young adults – particularly those of low-income families. 
Sugar sweetened beverages represent the main source of fructose intake and in young adults 
this accounts for as high as 20% of daily energy consumption [17, 185]. 
Since preclinical studies indicate that a diet high in both fructose and salt results in 
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hypertension, aortic stiffness, and early diastolic dysfunction, the question arises whether 
ingestion of high fructose and salt during a critical early life period predisposes to salt-
sensitive hypertension and cardiovascular dysfunction in later life [41, 42, 66, 163, 186]. 
Particularly with cardiovascular development, rat models have shown that interventions 
during critical time periods of ontogeny known as developmental windows, may alter 
susceptibility to hypertension later in life and induce substantial physiologic and anatomical 
changes that render the animal prone to subsequent cardiovascular co-morbidities [187]. 
Currently, the predominant insights regarding how post-gestational insults affect arterial 
pressure development can be garnered from studies using genetically hypertensive strains 
rat (dahl salt-sensitive and spontaneously hypertensive, namely) to investigate the effects of 
environmental and genetic factors and their impact on disease progression [187]. In cases of 
salt-sensitivity, severe salt-deprivation during critical developmental periods (4-9 weeks) 
blunts hypertensive development while increased sodium intake accentuates it [188-190].   
 Salt-sensitivity can be assessed clinically using a variety of protocols; however, it can 
be defined generally as a 5-10% change in arterial pressure following a change in dietary 
sodium intake [191, 192]. We recently tested the hypothesis that a 20% fructose and 4% 
sodium diet provided early in life rats renders the animal prone to salt-sensitive 
hypertension later in life (Chapter 3). The purpose of the present study was to investigate 
the longitudinal functional alterations to function to provide mechanistic insights into 
disease progression. We hypothesized that rats consuming a diet with 20% fructose and with 
or without 4% sodium during weeks five to eight (inclusive) will develop elevated blood 
pressure, reduced arterial compliance, and diastolic left ventricular dysfunction in 




All animal procedures and protocols were approved by the Wayne State University 
Institutional Animal Care and Use Committee (Protocol #19-03-1001). Animal care and 
experimentation was conducted in accordance with the guidelines and principles of National 
Institutes of Health Guide for the Care and Use of Laboratory Animals. Male Sprague Dawley 
rats (Envigo Sprague Dawley, Shelby, MI) were housed under controlled conditions (21–
23°C; 12 hr light and 12 hr dark cycles, lighting period beginning at 6 AM).  
Dietary	regimen 
Upon arrival rats were permitted to acclimate for at least 48 hours and provided 
standard lab chow and water, ad	libitum. As depicted in Figure 1, when rats reached ~4.5 
weeks of age and ~125 grams, a hemodynamic transmitter was implanted and the animal 
was permitted to recover in individual standard polyurethane caging. One week later, rats 
were placed into metabolic housing units (Tecniplast USA, West Chester, PA) and provided 
milled feed containing either 20% glucose and 0.4% Na+ (glucose low salt – GLS, ModTest 
Diet® 5755 – 5WZZ) or 20% fructose and 0.4% Na+ (fructose low salt - FLS, ModTest Diet® 
5755 - 5W3Y). Rats were permitted a 3-day acclimation period followed by a 3-day baseline 
period where food and water were provided ad	libitum. GLS rats (n = 9) were continued on 
the same diet. Rats receiving FLS chow were then randomly assigned into continue on FLS 
(n= 9) or 20% fructose and 4.0% Na+ (fructose high salt – FHS, ModTest Diet® 5755 – 5WZ8; 
n = 18).  At this time, a pair feeding paradigm was initiated among groups to achieve equal 
caloric intake among the groups on a day-to-day basis.  Water continued to be provided ad	
libitum.	The diets were maintained for three weeks (Fig 4.1, weeks 2 to 4) during which fluid 
and urine outputs were assessed daily. The rats were then returned to standard individual 
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housing units (Figure 4.1, weeks 5 to 7). Rats on GLS feed were maintained on this diet for 
the remainder of the study. All rats on FLS feed were then placed on GLS chow. The rats on 
FHS chow were then further randomly assigned to receive GLS feeding (n = 9) or to continue 
the FHS diet (n = 10).  The rats on FHS during Phase 2 remained on FHS through to the end 
of the study.   
After 3 weeks, rats were returned to a metabolic cages and permitted to acclimate to 
the change in caging for three days. FLS and FHS fed rats that had been shifted to a GLS feed 
were then subjected to a high salt challenge without fructose for the remainder of the 
protocol using a 20% glucose and 4.0% Na+ chow (glucose high salt – GHS, ModTest Diet® 
5755 – 5WOW). This produced four groups characterized by their dietary regimens in the 
early and late phases – Phase 1 and Phase 3, respectively (Figure 4.1) - of the protocol: a) 
GLS-GLS, b) FLS-GHS, c) FHS-GHS, and d) FHS-FHS. Rats were maintained on these diets for 
an additional 3 weeks; thereafter terminal studies were performed. 
Surgical	procedures	
All surgical procedures were conducted under intraperitoneal ketamine (80 mg/kg; 
Mylan Institutional, LLC Rockford, IL) and xylazine (10 mg/kg; Akorn Animal Health, Inc., 
Lake Forest, IL) anesthesia and subcutaneous administration of buprenorphine SR (0.3 
mg/kg) for analgesia.  
Hemodynamic Transmitter Placement. Following right femoral artery isolation, a 
small arterial incision was made, and the gel-filled catheter of the hemodynamic transmitter 
(HDS-10, Data Sciences International, MN) was inserted into the vessel and advanced into 
the abdominal aorta. The catheter was then anchored in place within the femoral artery 
using 3-0 silk suture (Ethicon, Johnson & Johnson, New Brunswick, NJ) and the transmitter 
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body was subcutaneously tunneled to the right flank. Subcutaneous adipose tissue was 






































































































































































































































































Vascular Catheter Placement. At the end of Phase III, catheters were placed into the 
left carotid artery and external jugular vein using the anesthetic and analgesic regimen above 
and as previously performed in our laboratory [42, 163]. Catheters were anchored using 3-
0 silk suture and tunneled subcutaneously behind the scapulae for exteriorization. All 
incisions were closed using 4-0 Prolene suture (Ethicon, Johnson & Johnson, New Brunswick, 
NJ). The catheters were then filled with heparinized saline (1000 units/mL) and secured. 
The rats were then permitted to recover in individually housed polyurethane cages.  
Ultrasonography	
At the end of Phases I and III, rats were anesthetized in an induction chamber using 
3% isoflurane and transferred to a pre-heated electronic ECG platform where 1-1.5% 
isoflurane was delivered via nosecone to maintain a sufficient plane of anesthesia. Fur from 
the chest and abdominal area was removed using an electric shaver followed by application 
of depilatory cream (Pharmaceutical Innovations, Newark, NJ). Electrode gel was placed on 
each of the ECG strips and the rat’s limbs were situated in place using tape. Body temperature 
was measured via a rectal probe and contact gel preheated to 37°C was applied before 
performing echocardiography according to standard methods [103, 104].  
Image acquisition was performed using the Vevo3100 Imaging system and MX250S 
transducer (Fujifilm Visualsonics, Inc., Toronto, ON). Assessment of left ventricular (LV) 
dimensions and systolic function was assessed using a short axis view in M-mode at the level 
of the papillary muscle. Left ventricular (LV) diastolic filling and function was assessed using 
pulsed wave doppler of transmitral blood flow velocities. These were located using color 
imaging superimposed over an apical four-chamber view. Myocardial function assessment 
was conducted using tissue doppler imaging (TDI) near the mitral annulus measured along 
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the apical axis. Pulse wave velocity (PWV) determination within the aortic arch was made 
via the determination of pulse transit time from the LV to a location measured proximally 
along the ascending aortic arch and one measured distally along the thoracic descending 
aorta. Distance between these points was measured using a B-mode image of this anatomical 
segment. Aortic PWV was calculated as the difference in pulse transit time (calculated using 
an ECG tracing as a reference) measured at these two points divided by the distance between 
them.  
Renal resistive index (RRI) was determined using pulsed doppler measurements 
along the left main renal artery. RRI was calculated by taking the difference between systolic 
and diastolic velocity divided by the diastolic velocity at that time point [98]. Data analysis 
was performed offline using VevoLab and VevoVasc software (Fujifilm Visualsonics, Inc., 
Toronto, ON) in blinded fashion.  
Analytical	measurements	and	calculations 	
Hemodynamic Telemetry. Acquisition of hemodynamic data was conducted using 
Ponemah software (Data Sciences International, MN). Systolic blood pressure (SBP), 
diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were 
sampled for 10 seconds every 4 minutes at a sampling rate of 500 samples/second. Pulse 
pressure (PP) was calculated separately using these values. Baseline measurements were 
averaged over three days after cage acclimation. Sampling was performed at this rate 
continuously throughout Phases I and III within the metabolic cages. 
Metabolic and Hormonal Assessment. Chow consumption was measured 
gravimetrically daily and caloric and sodium (Na+) values were determined based on dietary 
profiles for each feed.  
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At the end of Phase III and prior to terminal harvest, food was removed from caging 
at the beginning of the morning light cycles and terminal procedures were conducted at a 
minimum of 6 hours later to promote a semi-fasting state (as permitted by our Animal Use 
Committee). Glucose levels were determined using a One-Touch Ultra glucose monitor 
(LifeScan, Inc., Malpitas, CA) on 50 µl blood from the arterial catheter. Arterial blood was 
collected into pre-chilled tubes containing ethylenediaminetetraacetic acid (EDTA) for 
plasma renin activity and into separate pre-chilled tubes containing 120 μL of 500 mM 
sodium EDTA, 125 mM phenanthroline, 1 mM phenylmethanesulfonyl fluoride, 20 mM 
pepstatin, 1 mM enalapril and 10X phosphatase inhibitor cocktail for insulin. Once collected, 
blood was immediately centrifuged at 3000 rpm for 4 minutes at 4°C. Plasma was stored at 
-70°C until assay.  PRA and insulin levels were measured using a standard Elisa kits (IBL 
International, Hamburg, Germany and Bertin Pharma SAS, Montingny-le-Bretonneux, 
France, respectively) Insulin sensitivity was calculated using the ratio of plasma glucose to 
insulin levels which was collected following a 6-hour minimum fasting period.  
Rats were euthanized using sodium pentobarbital (120 mg/kg, IV) and hearts were 
excised and preserved in formalin solution for 24-48 hours before embedding for 
histological assessment.  
Statistics. All values are presented as mean ± standard error (SE). One-way analysis 
of variance (ANOVA) was used to determine differences among groups with a Sidak’s 
multiple comparisons test for post‐hoc analysis. To limit unnecessary reductions in adjusted 
statistical power resulting from excessive comparisons, once trends were discerned 
individual Holm-Sidak’s tests were conducted on pre-selected groups. Two-way ANOVA’s 
with repeated measures were performed to compare differences over time using a Sidak’s 
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multiple comparisons test for post‐hoc	analysis. A P-value less than 0.05 was considered 
statistically significant. Due to the technical nature of many of these experimental techniques 
that required data acquisition of pre-determined anatomic sites for rigorous and 
reproducible analysis, N-values may differ across groups. 
RESULTS	
Caloric	and	 sodium	 intakes.	During baseline recordings, all rats in metabolic cages 
were placed on a pair feeding paradigm. Due to small but measurable differences in caloric 
profiles among diets, pair feeding was conducted using caloric consumption as an index 
rather than direct chow weight. Despite careful attempts to match caloric intakes, statistical 
differences among caloric intakes were observed following dietary changes from low salt to 
high salt feeds in Phase I, week 1 (FHS group) and in Phase III weeks 1 and 2 (FLS-GHS, FHS-
GHS). Caloric intakes were no different among the groups by of week 2 of Phase I and III 
except of the FLS-GHS group in Phase III that continued to ingest fewer calories (Table 4.1). 
Low salt fed rats consumed approximately 10% of the amount of sodium consumed by high 













































GLS	 9 61.5±5 3.0± 0.3 68.4±4 3.0± 0.1 66.0±6 2.9± 0.1 
FLS	 9 60.7±8 2.7± 0.1 67.2±4 3.0± 0.1 65.7±5 3.2±0.3 


























GLS‐GLS	 9 62.6±6 2.8± 0.1 63.5±6 2.9± 0.1 64.3±5 2.8± 0.1 
FLS‐GHS	 9 45.9±5* 22.1±0.8*† 54.4±4* 26.2±0.7* 57.1±4† 27.5±0.6* 
FHS‐GHS	 8 50.1±7* 23.3±1.2* 56.1±6* 26.0±0.8* 59.9±6 27.7±0.6* 
FHS‐FHS	 9 60.5±5 27.5±0.8* 63.9±6 29.0±0.3* 66.4±8 29.9±1.0* 
Table and data reconstituted from Chapter 3. Daily collection measurements recorded at 5 PM each day. Caloric 
intake calculated using caloric profiles of 3.98 kcal/g and 3.61 kcal/g for low salt and high salt feed, 
respectively. Values are indicated as mean ± SE, N as indicated per group; *p<0.05 vs. GLS-GLS controls; †-
-p<0.05 vs. FHS-FHS controls. 
 
Hemodynamic	effects.	In Phase I, the addition of high salt in the diet of fructose fed 
rats led to a progressive increase in mean arterial pressure that was significantly elevated 
after four days (Data shown in Chapter 3, Figure 3.2). This increase was sustained for the 
subsequent two weeks. By the end of Phase I, the MAP had risen in all groups consistent with 
expected changes in blood pressure with maturation. Whereas the MAP did not differ among 
the groups at the end of Phase I, the change between baseline and final MAP values in the 
FHS group was statistically greater than that of other groups (P<0.01; Table 4.1A). The 
addition of high dietary salt to the FLS-GHS and FHS-GHS groups in Phase III led to significant 






A.) Hemodynamic calculations for MAP throughout phases. N-values are as follows: GLS – 9, FLS – 7, FHS – 18. 
B.) Study-wide changes in hemodynamics calculated as the difference between measurements taken at the end 
of Phase III and the baseline measurements taken at the beginning of Phase I. Values are indicated as mean ± 
SE, N as indicated per group; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS controls. 
After the rats that had received fructose in Phase I with either low salt or high salt, 
were fed glucose-containing chow with high salt (FSL-GHS and FHS-GHS) or had been 
maintained on fructose and high salt throughout the protocol (FHS-FHS), systolic blood 
pressures at the end of Phase III had increased significantly compared with the GLS-GLS 
group that had ingested glucose and low salt chow throughout the study (p<0.05). Diastolic 
blood pressures did not differ across any of the groups; MAP was significantly greater only 
in the FHS-FHS rats (p<0.01). Therefore, the increases in MAP were driven predominately 
by systolic mechanisms. This did not, however, lead to a significant increase in pulse 
pressure. Additionally, no differences existed among groups when heart rate was assessed. 
Early	 and	 late	 impairment	 of	 vascular	 compliance.	 Echocardiography and 
ultrasonography studies were performed immediately upon completion of Phases I and III. 
Regional measurements of vascular compliance were taken throughout the aortic arch and 
	 PHASE	I PHASE	3 
MAP	
(MMHG)	 GLS	 FLS	 FHS	 GLS‐FHS	 FLS‐GHS	 FHS‐GHS	 FHS‐FHS	
BASELINE	 100.7±0.6 100.7±2.5 99.9±3.5 109.3±1.9 111.9±1.1 111.2±1.8 113.7±1.7 


















GLS‐GLS	 7 10.0±1.0 11±2.2 11±1.2 -92±11 2.4±1.5 
FLS‐GHS	 8 15±0.9* 18±0.9* 14±1.3 -103±18 4.2±1.6 
FHS‐GHS 8 15±1.4* 18±1.7* 13±1.7 -105±6 4.2±2.0 





the left main renal artery to assess PWV and RRI, respectively. In Phase I, FHS diet 
significantly increased PWV of the thoracic aorta, thereby indicating decreased aortic 
compliance compared to the GLS group (Figure 4.2). Maintenance of this diet throughout the 	
protocol led to a significant increase in PWV in Phase III in both the FHS-GHS and FHS-FHS 
groups. No differences were observed in RRI of any of the groups at the end of Phase I (Figure  
4.3). Similar to PWV values, FHS-GHS and FHS-FHS groups in Phase III displayed a 
statistically higher RRI than GLS-GLS rats. These trends were only elevated in Phase III and 
demonstrated no intra-group variability when compared to Phase I by two-way ANOVA.  
 
Figure	4.2: Assessment	of	Aortic	Compliance. Measurements used for the assessment of thoracic aortic 
compliance in Phases 1 and 3. Values are indicated as mean ± SE, N values are as follows: GLS-8, FLS-8, FHS-18, 




Figure	4.3: Assessment	of	Renal	Resistive	 Index	 (RRI). Conducted in Phases 1 and 3. Doppler imaging 
measurements were made along the left main renal artery. Values are indicated as mean ± SE, N values are as 
follows: GLS-9, FLS-6, FHS-16, GLS-GLS – 8, FLS-GHS – 9, FHS-GHS – 7, FHS-FHS - 9; *P<0.05 vs. GLS-GLS 
controls.  
Table	4.3: Echocardiographic	Parameters	Assessed	at	the	End	of	Phase	III.	
Group	 GLS‐GLS	 FLS‐GHS	 FHS‐GHS	 FHS‐FHS	
N	 9 8 8 10 
LVEF	(%)	 74.9±3.4 77.3±4.4 80.3±3.7 78.2±2.3 
LVFS	(%)	 46.0±3.4 49.1±4.4 51.9±4.4 48.8±2.4 
LVSID	(mm)	 3.7±0.3 3.4±0.4 3.0±0.4 3.5±0.3 
LVDID	(mm)	 6.7±0.3 6.5±0.3 6.1±0.4 6.9±0.4 
LVAW;	Systole	(mm)	 3.2±0.1 3.3±0.2 3.5±0.2 3.6±0.1 
LVAW;	Diastole	(mm)	 1.94±0.03 2.0±0.09 2.5±0.08** 2.2±0.14* 
LVPW;	Systole	(mm)	 3.5±0.1 3.5±0.2 4.0±0.3 4.0±0.2 
LVPW;	Diastole	(mm)	 2.3±0.1 2.4±0.1 3.0±0.3* 2.7±0.2 
LVTW;	Systole	(mm)	 6.8±0.2 6.8±0.4 7.4±0.3 7.6±0.4 
LVTW;	Diastole	(mm)	 4.3±0.1 4.4±0.2 5.6±0.4** 4.9±0.3 
LV	Mass	(mg)	 1190±73 1060±59 1401±56* 1373.0±75* 
Abbreviations: LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVSID, left 
ventricular systolic internal diameter; LVDID, left ventricular diastolic internal diameter; LVAW, left 
ventricular anterior wall width; LVPW, left ventricular posterior wall width; LVTW, left ventricular total wall 
width; LV Mass, Left ventricular mass. Values are mean ± SE, n as indicated per group; *P<0.05 vs. GLS-GLS 
controls. 
Echocardiographic	assessment	of	dietary	impacts.	Physical assessment of the LV was 
performed using a short axis view and M-mode imaging. Table 4.3 depicts the results of LV 
echocardiography performed at the end of Phase III. No effect on standard systolic functional 
measures such as ejection fraction and fractional shortening were observed. LV mass 
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significantly increased in FHS-FHS and FHS-GHS test groups. Further assessment of 
structural morphology found changes in anterior and posterior wall thickness in FHS-GHS 
groups; these changes were more only significant during diastole. In the FHS-FHS group LV 
thickness only reached significance in the anterior wall. When assessed as a ratio of total 
wall thickness (sum of anterior and posterior walls) to diastolic diameter (radius cavity), 
there was a significant reduction in the ratio in FHS-GHS rats when compared with that of 
the GLS-GLS group (Figure 4.4). Taken together these measurements are indicative of 
ventricular hypertrophy and concentric remodeling.  
 
 
Table 4.4 depicts further functional assessment conducted by way of pulsed and 
Figure	4.5. Assessment	of	Left	Ventricular	Morphology	in	Phase	III. Conducted under a short axis view of
the left ventricle using M-Mode. Total wall thickness is assessed as the sum of anterior and posterior LV wall
widths and LV Wall/Radius cavity is assessed as the ratio of total wall thickness and end-diastolic diameter. 
Values are indicated as mean ± SE, N as indicated per group; *P<0.05 vs. GLS-GLS controls. 
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tissue doppler imaging of the mitral valve area. The ratio of early to late phase filling (E/A) 
demonstrated significant reductions in the FHS-FHS group. Values for E/A in Phase I and III, 
respectively, are shown in Figure 4.5. Reductions in the E/A ratio in the FLS-GHS and FHS-
GHS test groups were also observed, although these values did not achieve significance. 
Likewise, decreases in mitral valve deceleration time were also observed across all groups 
when compared to the GLS-GLS group, however these were only significant in the FHS-FHS 
group.  In contrasting to these abnormal flow patterns, TDI did not observe any remarkable 
differences among groups. 
Table	4.4: Parameters	Associated	with	Diastolic	Function	Assessed	at	the	End	of	Phase	
III. 
Abbreviations: E, early phase ventricular filling; A, late phase ventricular filling; DT, mitral valve deceleration 
time; MV Area, mitral valve area; IVRT, isovolumetric relaxation time; E’, mitral annulus early phase filling; A’ 
Values are mean ± SE, n as indicated per group; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS controls. 
łp<0.05 vs. GLS-GLS controls via unpaired student’s t-test. 
	 Group	 GLS‐GLS	 FLS‐GHS	 FHS‐GHS	 FHS‐FHS	
N	 9 8 8 10 
Peak	E	(mm/s)	 706±22 630±45 652±41 641±39 
Peak	A	(mm/s)	 555±27 550±44 576±34 621±32 
E/A	 1.31±0.06 1.16±0.06 1.14±0.06* 1.03±0.04** 
DT	(ms)	 39.5±4.0 28.0±2.2* 31.8±3.0 25.4±2.3** 
IVRT	(ms)	 25.5±1.0 27.7±1.5 27.6±1.1 29.0±0.9ł 
E’(mm/s)	 34.1±2.6 32.3±4.6 34.2±4.0 27.4±1.8 
A’(mm/s)	 45.3±3.7 45.8±4.7 48±4.9 47.1±4.7 
E/E’	 22.5±1.9 25.2±6.2 21.1±3.3 24.3±2.3 




Figure	 4.5: Assessment	 of	Diastolic	 Function.	 Assessment of blood flow across the mitral valve as an 
indicator of diastolic function using the ratio of early phase left ventricular filling (E-Wave) and late phase left 
ventricular filling induced by atrial contraction (A-Wave) Values are indicated as mean ± SE, GLS-9, FLS-7, FHS-
18, GLS-GLS – 10, FLS-GHS – 9, FHS-GHS – 9, FHS-FHS - 10; *p<0.05 vs. GLS-GLS controls, **p<0.01 vs. GLS-GLS 
controls.  
 
Metabolic profiles are shown in Table 4.5. Initial weights and final weights 
demonstrated no differences among rats on different dietary regimens. FLS-GHS fed rats had 
a small, but insignificantly lower final body weight which was attributed to reduced caloric 
consumption at the beginning of Phase III following the change in chow from glucose with 
low salt to glucose with high salt content. Plasma glucose and insulin levels did not vary 
among the groups and were comparable to either vendor specifications for standard 
Sprague-Dawley rats on standard diets and rats fed control diets with no added sugar in 
similar studies [193-195]. Glucose: insulin ratio was significantly lower in the FHS-GHS 
group compared with GLS-GLS and FLS-GHS groups. FHS-FHS rats had an attenuated 
glucose:insulin ratio, but this was not significant. PRA was significantly reduced in FLS-GHS 
groups following high salt challenge at the end of Phase III. FHS-FHS rats had a similar, albeit 
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slightly blunted, inhibition of renin secretion that has been witnessed in prior studies [42]. 
Following high salt challenge, PRA was lower in FHS-GHS rats compared with GLS-GLS rats 
but did not achieve significance. 
Table	4.5: Metabolic	and	Endocrine	Assessment. 
Assay values conducted using blood samples collected through an intra-arterial line extracted under conscious 
conditions. Rats were fasted for a minimum of 6 hours prior to collection. Values are indicated as mean ± SE, N 
as indicated per group; *P<0.05 vs. GLS-GLS controls, **P<0.01 vs. GLS-GLS controls. Due to technical 
complications, G:I (Glucose:Insulin) ratio N values differ and are as follows: GLS-GLS -5 , FLS-GHS - 6, FHS-GHS 
- 7, FHS-FHS - 7.   *NOTE: Table adapted from Chapter 3, Table 4.	
DISCUSSION	
The major findings of this study support the hypothesis that fructose plus high salt 
programming early in life can have profound cardiovascular impacts in adulthood following 
the addition of high dietary sodium. Chronic feeding of FHS diet in our FHS-FHS group 
elicited more pronounced  consequences than noted in prior studies conducted by our lab 
such as reduced aortic compliance and diastolic dysfunction [163]. Of note is the similar –
findings in cardiovascular parameters in FHS-GHS and FHS-FHS groups.  
The addition of high salt to rats primed with a fructose diet elicits an increase in MAP 
driven by significant increases in systolic blood pressure. Slight increases in diastolic blood 
pressure occurred which prevented any statistically significant increases in pulse pressure. 
Study-wide increases in MAP where similar throughout all 3 groups fed with fructose. 
However, the statistically elevated MAP in the FLS-GHS groups were the result of the large 























GLS‐GLS	 9 125±4 381±9 3.3±0.1 128±13 1.14±0.23 64.7±6.4 1.82±0.20 
FLS‐GHS	 9 132±4 347±10 3.4±0.1 129±24 0.74±0.12 74.6±12.6 0.66±0.12** 
FHS‐GHS	 8 128±3 362±12 3.2±0.1 126±14 1.33±0.12 31.6±1.9* 1.35±0.28 
FHS‐FHS	 9 127±5 366±12 3.4±0.1 118±11 1.03±0.17 43.0±8.3 1.09±0.29* 
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that fructose alone (without the addition of high salt) is sufficient to chronically predispose 
the kidney to states of heightened salt-sensitivity that can lead to hypertension. Although the 
FLS-GHS group reach similar extents of hypertension, the problematic maladaptation of 
vascular stiffening and LV dysfunction were not as apparent as in other groups.  
Pathologies underlying fructose-induced hypertension are increased sympathetic 
activity, endothelial dysfunction, and increased sodium retention leading to increased 
extracellular volume [52, 77]. Increased extracellular volume in the FHS group of Phase I is 
likely to play a large role in producing the increases in MAP. Increased extracellular volume 
is unlikely to be the only governing factor in prolonged FHS feeding, however. Indeed, 
increased arterial pressure over time alone can induce cellular and molecular alterations 
that deform the vascular wall [109]. Further, prolonged fructose feeding is associated with 
hyperinsulinemia which can cause increased circulating levels of endothelin-1 (ET-1), Ang 
II, and uric acid [32, 80, 196, 197]. It is of note that no significant differences in insulin levels 
or calculated insulin resistance via our modified G:I ratio approach were observed among 
groups. No evidence of hyperglycemia was present either. While it cannot be definitively 
concluded in this study that altered insulin signaling had no effect, the impact was likely 
nominal. Alternative pathologies such as reactive oxygen species (ROS) are more likely 
implicated in the observed endothelial dysfunction [66, 163]. 
Evidence of vascular dysfunction becomes evident in FHS groups by the end of Phase 
I as demonstrated by increased PWV, but in Phase III this effect becomes exacerbated in FHS-
FHS groups both when compared to Phase III GLS-GLS controls as well as when compared to 
initial Phase I measurements using 2-way ANOVA with repeated measures. FHS-GHS fed rats 
exhibit a significant increase in PWV in Phase III that was not significantly elevated from 
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Phase I. Whether this is residual arterial dysfunction from Phase I or the result of additional 
factors is unclear. However, PRA was not significantly reduced from GLS-GLS controls at the 
time of terminal harvest despite the positive sodium balance observed in the FHS-GHS group. 
These levels differed from the significantly reduced PRA levels in FLS-GHS and FHS-FHS 
groups, indicating a contribution of the RAAS in maintaining the elevated MAP by the end of 
Phase III.  
Numerous studies have been conducted to determine the capacity for clinical 
applicability of the renal resistive index (RRI) in determining renal function in association 
with the progression of hypertension, chronic nephropathy, and diabetes mellitus [198-
201]. Further, many additional studies have found functional correlation between elevated 
RRI and intrarenal perfusion and renovascular resistance, but also correlation to various 
pathological conditions that occur in many of the above-mentioned diseases, such as 
tubulointerstitial damage and renal atherosclerosis [202-204].   
While there is still controversy over the reliability of RRI as a measurement across all 
diseases [205], there is a general consensus regarding its relation to adverse cardiac and 
renal outcomes in hypertension [206, 207].  We observed significant increases in RRI in FHS-
FHS and FHS-GHS groups only in Phase III. In some circumstances, the increase in renal 
artery resistance is a product of prolonged activation and/or resetting of renal 
autoregulatory mechanisms such as the myogenic response or tubuloglomerular feedback 
[208]. However, given the unremarkable response in RRI in the FLS-GHS group but statistical 
increase in FHS-GHS group to high salt challenge, it is unlikely that autoregulatory 
mechanisms play a significant role. Alternatively, renal resistance is also suspectable to 
changes in upstream and downstream vascular compliance and has been correlated to 
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increased pulsatility [98]. Concurrent with this theory is the decreased thoracic aortic 
compliance (calculated by PWV) observed in this present study.  
Total peripheral resistance is a function of MAP and heart rate - an increase in either 
factor without a corresponding decrease in the other elevates total peripheral resistance 
[209]. In this study, this physiologic dysfunction is observed as both an increase in general 
systemic resistance and in lack of local aortic compliance. The net effect of these factors is an 
increase in ventricular afterload which can lead to left ventricular remodeling and 
subsequent hypertrophy [210]. Prior to the development of heart failure are the occurrence 
of early signs and symptoms of ventricular remodeling and mechanical dysfunction [211]. 
The significantly reduced E/A ratio in both FHS-GHS and FHS-FHS groups was evidence of 
diastolic dysfunction. In each of these groups ventricular wall sizes were increased, although 
this only statistically significant in FHS-GHS groups when compared to GLS-GLS controls. 
This implies hypertrophic growth that when assessed as a ratio of ventricular wall thickness 
to end-diastolic cavity size, a significant increase is observed. These changes did not result, 
however, in an overall increase in cardiac mass. These findings are consistent with 
concentric remodeling of the heart which is generally induced by chronic conditions of 
pressure-overload, such as in hypertension [212]. 
Whereas ventricular remodeling was not as pronounced in rats chronically fed FHS 
chow compared to the FHS-GHS group, mechanical dysfunction was more distinct. The 
decrease in the ratio of early to late diastolic filling was accompanied by an increase in 
isovolumetric relaxation time and decrease in mitral valve deceleration time. Mitral valve 
area is contrived from deceleration time and was therefore significantly increased. 
Shortening of the mitral valve deceleration time implies restrictive filling and has been 
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positively correlated to severe adverse cardiac events [213]. Each of these measurements 
are indicative of diastolic dysfunction and are phenotypes associated with either the 
development or presence of cardiomyopathy [214-216]. 
Limitations	
Due to the overall protocol time length and material requirements, it was necessary 
to implement experimental group limitations to maintain consistent and equal allotment of 
animals into specified groups throughout each batch. Previous studies from differing labs 
have found no significant changes in arterial pressure or bodily sodium balance in rats fed a 
glucose and high salt diet in both acute and chronic settings. Concurrent with this are 
observations of no change in ultrasound and echocardiography studies. While the timeline 
of the study at present exceeds that of prior studies, we feel that our current choice of 
negative (GLS-GLS) and positive (FHS-FHS) control groups was sufficient to satisfactorily 
demonstrate changes associated with short term administration of high salt diet later in life.  
Sex hormones play an important role in the development of hypertension following a 
high fructose diet. Female rats have been shown to be particularly resistant to the 
development of insulin resistance and therefore hyperinsulinemia specifically due to the 
presence of differing sex hormones. The purpose of this model is to demonstrate that 
hypertension can be induced using dietary regimens relevant to moderate consumption 
levels observed in modern society, and therefor with limited effects of insulin. While these 
effects are limited, they cannot be entirely negated; effective comparisons among groups 
with previous findings therefore necessitated the use of only one sex.  Studies in female rats 





Several studies demonstrating the effects of chronic carbohydrate consumption and 
the development of cardiomyopathy and heart failure exist, but these specifically rely on the 
development of diabetes and the associated pathologies [214, 217]. Hyperglycemia, 
hyperinsulinemia, and insulin resistance are associated even with pre-diabetic states and 
play an important role in developing the observed cardiovascular abnormalities  [186]. In 
the present study we did not find remarkable evidence of any of these pathologies. The 
administration of free radical scavengers in this model prevents the development of 
hypertension and ameliorates aortic stiffening in matured rats [66, 163]. The vascular insults 
observed via ultrasound following Phase I grew progressively worse in the FHS-FHS controls 
and likely played a considerable pathologic role in the developed diastolic dysfunction. As 
the FLS-GHS groups did not display any aortic stiffening following the high salt challenge in 
Phase III, it can be speculated that what was observed in the FHS-GHS group was in part 
residual reductions in compliance from Phase I that may have been exacerbated by the 
addition of high dietary sodium. Alternatively, the exposure to both fructose and high salt 
early in life in Phase I is an important factor for later development of the vasculopathy and 
cardiomyopathy. 
On the other hand, fructose feeding alone, without the addition of high dietary sodium 
during the critical developmental period is sufficient to induce as state of salt-sensitivity 
later in life which renders the body susceptible to hypertension. Chronically this can lead to 
various cardiac and renal co-morbidities such as heart failure and chronic kidney disease 
[218, 219]. Even FLS-GHS groups that became hypertensive only later in life had a reduction 
in diastolic function, indicated by the E/A ratio, but this was not significant. Contrastingly, 
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the addition of high salt to a moderate fructose diet during pubescent, developmental years 
had lasting effects on cardiac and renal function evidenced by diastolic dysfunction, 
ventricular hypertrophy, and failed renin suppression. This detriment occurred in rats that 
were fed this fructose and high salt diet chronically and those that were allowed a period of 
reprise from poor dietary conditions (FHS-GHS) groups. Indeed, diets with fructose fed early 
in life - with or without the presence of elevated sodium - promote adaptations that render 
the body increasingly vulnerable to complications caused by even modest dietary insults; 







The present studies indicate that consumption of even a moderate fructose diet 
induces states of salt-sensitivity that can result in hypervolemia and rapid induction of 
hypertension. The robust initial increase in arterial pressure does not necessarily continue 
to progress as numerous regulatory mechanisms such as diuresis become increasingly 
active. While these responses are sufficient to curb the rising arterial pressure, they are 
unable to entirely restore normotensive states, indicating abnormally functioning regulatory 
systems. The result is a modest overall increase in arterial pressure that can lead to 
cardiovascular and renal dysfunction in relatively short periods of time.  
Whereas further studies are necessary to determine the permanence of fructose-
induced complications, it is apparent from the studies at present that provision of fructose 
during developmental periods in youth leads to a programmed salt-sensitivity which extend 
into adulthood. In this model the salt-sensitivity is driven by renal mechanisms. A 
particularly novel observation made in these studies was that this state of salt-sensitivity is 
no longer dependent on the concomitant consumption of fructose. Further, the increases in 
arterial pressure that arise from the addition of high dietary sodium are accompanied by 
phonotypes of cardiovascular and renal dysfunction similar in nature and extent to those of 
rats chronically fed a fructose and high sodium diet since early adolescence.  
The ratio of early to late phase ventricular filling (E/A ratio) assessed via trans-mitral 
flow imaging is effectively the most reliable indicator of diastolic function. Unfortunately, 
there is an inherent degree of bluntness behind its use as it serves as an overall index of 
function and provides very little mechanistic insight, thereby necessitating several other 
measurements to not only confirm the presence of dysfunction, but also to determine the 
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precise pathologic origins. Furthermore, it is subject to error particularly in animal models 
where heart rate is much higher than that of a human. Indeed, subjects with elevated resting 
heart rates make not only the discernment of E and A waves challenging, but it can also affect 
the magnitude itself of each wave form [220]. Such inaccuracies can ultimately sufficiently 
affect statistical analyses such that observable trends become dismissed.   
The dismissal of such trends is not indicative of Type 1 error so much as it is a result 
of various pitfalls associated with standard echocardiography. Regional measurements of 
the rate of deformation by which cardiac fibers displace themselves throughout the cardiac 
cycle, also known as strain and strain rate assessment, provides a unique methodology by 
which to measure changes in cardiac function. This technique observes trends in myocardial 
detriment with greater sensitivity and is favorable in instances in which frank cardiac 
disturbances are only beginning to manifest, such as in early stages of diabetes. Particularly 
in FLS-GHS groups, where the E/A ratio declined but ultimately did not reach significance, 
strain and strain rate assessment may provide additional insight. Furthermore, this 
technique may reveal preliminary changes that occur in youth that were previously 
unobservable. The subtlety by which diastolic dysfunction occurs in this model warrants 
further investigation. Early detection of these malignant adaptations is critical for the 
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 Dietary consumption of fructose facilitates increased intestinal fluid absorption and 
renal sodium reabsorption, thereby increasing fluid retention. The net result of this is a 
sustained increased in extracellular fluid volume that leads to states of hypervolemia and 
subsequent hypertension. Simultaneously, arterial pressure is being elevated by increased 
autonomic drive stemming from the sympathetic nervous system and various other 
endovascular proteins that induce vasoconstriction. Under these conditions, the addition of 
high dietary sodium promotes hypertension prior to the development of significant 
metabolic disturbances; the subtlety of which may go unnoticed by patients for prolonged 
periods. While much is understood regarding the multifactorial pathologies of this model of 
hypertension, few studies have investigated the chronic effects of this disease and the end-
organ damage that may result. The highest consumers of fructose are adolescents and young 
adults, and despite this demographic factor a disparity in the amount of research 
investigating the chronic effects of such a diet on developing physiologic systems exists. 
Using techniques such ultrasonography, telemetry, and metabolic caging systems, we sought 
to determine the acute and chronic effects of fructose and high salt feeding in both adult and 
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adolescent rats.  The results of these studies confirmed conclusions from prior studies in that 
fructose induces a state of salt-sensitivity. Over time this prolonged period of hypertension 
eventually leads to diastolic dysfunction and left ventricular hypertrophy.  The novel-most 
finding of this study, however, was the discovery that fructose feeding at a young age induces 
salt-sensitive states governed by renal mechanisms and that this sensitivity is retained into 
adulthood even following the restoration of a healthy diet. Taken together, these results 
indicate the inherent risks associated with moderate fructose consumption and highlight the 
importance healthy dietary habits in promoting cardiovascular and renal health throughout 
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